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“Don’t underestimate the power of vision and direction. These are 
irresistible forces, able to transform what might appear to be 
unconquerable obstacles into traversable pathways and expanding 
opportunities.” 
 
Jordan B. Peterson 
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Background. Abdominal aortic infections are rare, but dreaded disorders in vascular 
surgery. They are linked to high morbidity and mortality. Mycotic aneurysm as a primary 
infection of the abdominal aorta (MAAA) and an aortic graft infection (AGI) are different 
entities; however, due to bacterial presence in aorta and perivascular tissue, the 
principles of management are the same. Owing to the low incidence, high quality 
evidence is lacking to guide us towards the best surgical treatment method. Uncertainty 
exists, whether prosthetic aortic reconstructions in infectious conditions are utterly safe 
or whether biological reconstruction material should be preferred despite some 
shortcomings in durability. 
In complex abdominal surgery encompassing visceral aorta, prolonged aortic clamping 
above renal arteries is a risk factor for acute ischaemic kidney injury. In such situations, 
renal protection is recommended in order to avoid irreversible damage and renal 
replacement therapy.  
Aims. The aim of current study was to evaluate the infection resistance and durability of 
biological grafts as an aortic reconstruction material in abdominal aortic infections (AGI 
and MAAA) and to estimate the mortality after such reconstructions. Furthermore, 
efficacy of temporary axillo-renal bypass in prevention of renal ischaemic damage from 
major aortic surgery was estimated. 
Materials. The study comprises two parts. In the first part, 132 patients were 
retrospectively analysed after being treated for aorto-iliac infections with arterial 
resection and reconstruction with a biological graft. Study I included patients treated due 
to AGI with femoral vein grafts, Study II included patients in whom the arterial infection 
was treated using cryopreserved venous allografts, and Study III included patients who 
were treated with various biological grafts for a primary aortic infection. The primary 
endpoints were postoperative mortality and reinfection rates, secondary endpoints were 
treatment-related mortality, overall mortality and graft reinterventions. During the second 
part of the study, (Study IV) patients who underwent temporary axillo-renal bypass during 
a major aortic intervention were retrospectively analysed. Outcome measures were 
postoperative kidney injury, as defined by means of RIFLE classification, and 30-day 
mortality. Studies I, II and IV entailed retrospective analyses of patients treated at 
Helsinki University Hospital, while Study II was multicentre retrospective analysis of 
patients from six countries.   
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Results. Sixty-four percent (64%, n=85) of the patients underwent surgery for an 
abdominal aortic infection with autologous femoral veins (FV), 17% (n=23) with 
cryopreserved venous allografts (CVA), 9% (n=12) with xenopericardial tube grafts, 5% 
(n=7) with cryopreserved arterial allografts, and 4% (n=5) with fresh arterial allografts. 
Most common indications for operation were aortic graft infection (AGI) with an incidence 
of 51% (n=67) and mycotic abdominal aneurysm (MAAA) with 45% (n=60). The 30-day 
mortality was 9% for patients treated with FV for an AGI, 9% for patients treated for mixed 
infectious indications with cryopreserved venous allografts and 5% for patients treated 
with various biological reconstructions due to MAAA. The respective treatment-related 
mortality rates in these cohorts were 18%,13% and 9%. The reinfection rate was 2% 
(n=3) and 11% (n=14) of the grafts needed reinterventions at the mid-term follow-up, with 
stenotic lesions in femoral veins as the most common indication (n=9/14). Kaplan-Meier 
estimation of survival at 5 years was 59% (95% confidence interval, ?CI? 43% – 73%) for 
patients treated with FV due to AGI and 71% (95% CI 52% –89%) for patients treated 
with mixed biological materials for MAAA. For patients treated with cryopreserved 
allografts for mixed indications, estimated survival at 2-years was 70% (95% CI 49% – 
91%).  
Sixteen patients were operated with temporary axillo-renal bypass during aortic surgery.  
Despite short median renal ischaemia time of 24.5 minutes, 6 (38%) patients suffered 
acute kidney injury (AKI), of whom 4 had renal insufficiency preoperatively. One patient 
needed temporary renal replacement therapy, at one-month follow-up, however, renal 
function had returned to its baseline level or improved in all patients. The 30-day and in-
hospital mortality was nil. 
Conclusions. Biological reconstruction material is infection resistant and reasonably 
durable in midterm analysis. Early postoperative and overall mortality rates are 
acceptable after treatment of such a complex entity as abdominal aortic infections. 
Furthermore, temporary axillo-renal bypass is safe and feasible in diminishing acute 
kidney injury during major aortic surgery. 
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ABO A, B, AB and O blood types 
AEE aorto-enteric erosion 
AEF    aorto-enteric fistula 
AGI    aortic graft infection 
AKI acute kidney injury 
AXBF axillobifemoral bypass  
CAA cryopreserved arterial allograft 
CI confidence interval  
CKD chronic kidney disease 
CNS Coagulase-negative staphylococci  
CRP C-reactive protein  
CT  computed tomography 
CTA computed tomography angiography 
CVA cryopreserved venous allograft 
eg exempli gratia / for example 
ESRD end-stage renal disease 
etc et cetera /and other similar things 
EVAR endovascular aortic repair   
FDG PET fluorodeoxyglucose positron emission tomography 
FU follow-up 
FV femoral vein 
GFR glomerular filtration rate 
GI gastrointestinal 
HIV human immunodeficiency virus 
HUH Helsinki University Hospital 
KDIGO Kidney Diseases: Improving Global Outcomes 
MAA mycotic aortic aneurysm 
MAAA mycotic abdominal aortic aneurysm 
MRI  magnetic resonance imaging 
MRA magnetic resonance angiography 
MRSA methicillin-resistant Staphylococcus aureus  
NPWT negative-pressure wound treatment 
PCR polymerase chain reaction 
PMN  polymorphonuclear cells  
PTA percutaneous transluminal angioplasty 
PTFE  polytetrafluoroethylene 
RCT randomised controlled trial 
RIFLE Risk, Injury, Failure, Loss and End-stage renal disease – classification 
RRT renal replacement therapy  
SCr serum creatinine 
SMC smooth muscle cells 
spp species pluralis / multiple species  
XPT xenopericardial tube graft 
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Abdominal aortic infections are a challenge for vascular surgeons. Mycotic abdominal 
aortic aneurysm as a primary aortic infection is the consequence of arterial wall 
suppuration, and subsequent aneurysmal dilatation with a systemic infection. Rapid 
growth of the aneurysm sac induces pain and makes aneurysm prone to rupture. Aortic 
graft infection refers to prosthetic graft’s bacterial colonisation after aortic reconstruction. 
Bacterial inoculation occurs via perioperative contamination, haematogenous seeding or 
by development of aorto-enteric fistula. Symptoms may range from general malaise to 
septic shock and gastrointestinal bleeding in case of aorto-enteric fistula. Aortic infections 
are lethal without treatment and require surgery for the eradication of infection.   
The low incidence of 0.2%–3% of all abdominal aortic surgical disorders renders aortic 
infections rare vascular disorders (Berger et al 2015, Sörelius et al 2016, Argyrio et al 
2017). Downside of the rarity of these disorders is the low volume of patients, manifesting 
as a lack of extensive experience and high-quality evidence concerning best treatment 
methods. Current recommendations for management are based on single centre 
experiences and few retrospective multicentre studies. Data are frequently heterogenic, 
and conclusions are difficult to draw.  
In management of abdominal aortic infections, previous gold standard resection of 
infected aorta and extra-anatomical prosthetic bypass is replaced by in situ 
reconstructions. However, agreement on best reconstruction material is still lacking. 
Prosthetic reconstructions are feasible, but considerable risk of reinfection remains due 
to implantation of prosthetic material among infected tissue. Biological reconstructions 
are more infection-resistant, but some cause excessive surgical trauma to frail patients, 
and others are altered by long-term degenerations with lethal complications, or the graft 
material is difficult to retrieve. General agreement exists that endovascular aortic repair 
(EVAR) can be used as a bridge method for aortic infections, but in case of primary aortic 
infection EVAR is implemented as a definitive treatment method in numerous centres. 
Therefore, current management practices are individually assigned based on availability 
of treatment methods as well as centre’s experience and surgeons’ skills and made 
compatible with patients’ general condition without quality measurements to define the 
best care possible. 
Disorders extending to visceral aorta complicate the treatment even further. Suprarenal 
aortic clamping and visceral ischaemia increase the morbidity and mortality of aortic 
disease (Monnot et al 2016). Kidneys are the most susceptible to oxygen deprivation 
Abdominal Aortic Infections 
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developing an ischaemic injury in less than half an hour, which is frequently exceeded in 
case of complex anatomy (O’Donnell et al 2018). Several protection methods have been 
developed to diminish postoperative renal impairment; however, some are technically 
demanding, such as the left heart bypass, and others, such as a cold perfusion, are 
applicable for a short period only. Therefore, providing physiological pulsatile perfusion 
with easy access and low additional morbidity would be optimal in any surgery 
encompassing suprarenal aorta.  
In current study we evaluated the infection resistance and durability of biological grafts 
used as a reconstruction material for abdominal aortic infectious diseases. Furthermore, 
feasibility of temporary axillo-renal bypass as a renal protection method in major aortic 
surgery was assessed. 
Review of the Literature 
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The incidence of infection following aortic prosthetic reconstructions depends on the 
treatment method, indication and anastomotic sites. In case of aorto-iliac reconstruction 
– a totally intracavitary reconstruction – the reported infection rate is 0.3%–2% and rises 
up to 3% with distal anastomoses in the groin (Swain et al 2004, Vogel et al 2008, Berger 
et al 2015). In case of EVAR, the reported incidence remains even lower: 0.2%–1.4% 
(Antonios et al 2006, Hobbs et al 2010, Cernohorsky et al 2011, Fatima et al 2013, 
Argyrio et al 2017, Chafour et al 2017, Pettersson et al 2017). Aortoenteric fistulas (AEF) 
as the worst outcome infectious complications were expected to significantly decrease 
after introduction of endovascular aortic repair. However, albeit paradigm shift has 
happened, and overall incidence of infection has been reduced, the proportion of AEFs 
has remained as 1/3 of all AGIs (Reilly et al 1984, Fatima et al 2013, Kahlberg et al 2016, 
Lejay et al 2017). The peculiarity of the application of prosthetic grafts is that the device 
can get infected years after implantation and therefore overall incidence might be higher 
in the long term. Several biases affect the reported infection rate. Currently, most iliac 
occlusions and abdominal aortic aneurysms (AAA) are being treated endovascularly, 
leaving more time-consuming complex cases and reoperations for open surgery. 
Prolonged operation time and groin incisions are risk factors for AGI, and the infection 
rate may therefore seem elevated among patients treated with open repair (Antonios et 
al 2006, Berger et al 2015, Cheng et al 2017). Most of the AGI cases are concentrated 
in tertiary-level hospitals due to their complexity and the infection rate in these cohorts 
may thus appear higher. However, many surgical centres lack data on conservatively 
threated patients, since they are treated by internal medicine specialist or do not get 
referred to surgical unit possibly, thereby lowering the reported incidence. Patients also 
move and due to peculiarity of late onset of infection, they might be relocated from district 
of index operation hospital. (Berger et al 2015.)  
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Untreated symptomatic AGI is invariably fatal (Wilson et al 2016). The early survival rate 
of surgically treated AGI patients is currently 89%–92% and estimated 5-year survival 
51%–63%.  Reinfection is a prevalent treatment-related complication appearing in 4%–
11.5% of patients. (Seeger et al 2000, Oderich et al 2006, Ali et al 2009, Harlander-Locke 
et al 2014, Smeds et al 2016, Chaufour et al 2017.) In-situ reconstruction with prosthetic 
material offers the best short-term results, but the long-term outcome remains inferior to 
in situ reconstructions with biological material due to reinfections (O’Connor et al 2006, 
Batt et al 2018).  
Patients with AEF carry the worst prognosis in treatment of aortic infectious diseases 
(Oderich et al 2006, Ali et al 2009, Chaufour et al 2017). Early survival is 93% for 
endovascular treatment and 57% for open surgery. The advantage, however, dissolves 
fast due to the    higher rate of infectious complications (69% vs 41%), being 32%–66% 
for EVAR and 45%–44% for open repair in 2-years. (Danneels et al 2006, Bergqvist and 
Björck 2008, Ali et al 2009, Batt et al 2011, Chaufour et al 2017.) Estimated 5-year 
survival for conventionally treated patients with AEF remains reportedly less than 18% 
(Ali et al 2009, Batt et al 2011). Nevertheless, meticulous patient selection can result in 
an excellent 5-year survival of 59% with reinfection rate of 4% only, when AEF patients 
with no obvious purulence or abscesses are treated with in situ repair (Oderich et al 
2011). 
Infection diagnosis of aortic endograft is an absolute indication for conversion to achieve 
cure (Chaofour et al 2017, Lyons et al 2013). As a consequence of frequent suprarenal 
fixation, EVAR explantation requires supraceliac or suprarenal aortic clamping and 
aggressive manipulation of suspension hooks around visceral arteries carrying the risk 
of vessel dissection and visceral ischaemia. Therefore, risk for postoperative 
complications and subsequent mortality appears elevated. (Capoggia et al 2016, Hobson 
et al 2018, Schaefers et al 2019.) Following the explantation of an infected infrarenal 
EVAR device, 30-day mortality has been reported to be 26.6%–37.5% and overall 
mortality during follow-up up to 45.7% (Argyriou et al 2017, Schaefers et al 2019).  
??? ???????????????
There is no separate classification created especially for AGIs, but surgical site and 
vascular graft infection classifications take into consideration an intracavitary prosthetic 
grafts’ involvement and are used in literature to classify AGI. 
Review of the Literature 
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? Early < 4 months after implantation 
? Late > 4 months after implantation  
 
This classification is based on the normal disappearance of fluid collections around 
prosthetic graft to distinguish infectious collections from normal postoperative situation. 
Early infections appear during the first 4 months after implantation and are generally 
more aggressive, featuring more virulent bacteria (Staphylococcus aureus, gram-
negative bacteria) than late infections. Contamination is usually perioperative, due to a 
breakdown of aseptics or poor skin preparation or occurs during early postoperative 
period via wound infection or haematogenous route. Infection is often hospital-acquired 
and presents with fever, elevated biological markers, and it may evolve to sepsis. 
(Goldstone and Moore 1974, Szilagy et al 1972.) Late infections can also be acquired 
during the graft implantation, but causative agent is usually low-virulent bacteria, such as 
Staphylococcus epidermidis, which is capable of remaining indolent for years encased 
in biofilm. The infection may present with unexplainable fever episodes or manifest as 
systemic signs after stress caused by reoperation or superinfection. Cultures of low-
symptomatic perigraft tissue or fluid may reveal no bacterial growth (Bandyk et al 1991). 
If late AGI presents with gram-negative bacteraemia, aorto-enteral erosion (AAE) or AEF 
must be suspected (Inui and Bandyk 2015). 
 
????? SZILAGY’S CLASSIFICA??????
Szilagy classified wound infections in vascular surgery according to the depth of 
involvement. 
? Grade I – infection in dermal layer only 
? Grade II – infection extends to subcutaneous tissue, but does not involve arterial 
prosthesis 
? Grade III – infection involves arterial vascular prosthesis  
Grade I and II are superficial, appear in early postoperative period and often heal with 
adequate treatment with no significant clinical sequelae. AGI is classified as Grade III 
infection and despite its’ very low incidence, poses vast challenges in treatment and 
carries high morbidity and mortality. (Szilagi et al 1972.) 
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????? MODIFIED BUNT’S CLAS???????????
Bunt’s classification is based on the extent of graft involvement and the presence of 
complications (Bunt 1983, Cornenwett and Johnston 2010). In addition to aortic graft 
infections, original classification also includes infections of extra-anatomical grafts (P1) 
and prosthetic patch angioplasties (P3). In modified version these have been excluded 
to concentrate on AGIs only (Tebeeken et al 2012). 
? Graft infection 
- P0 graft infection – infection of a totally intracavitary graft (e.g. aorto-bi-
iliac graft, aortic stent graft) 
- P2 graft infection – infection of extra-cavitary portion of a graft, whose 
origin is cavitary (e.g. groin and graft limb infection of an aorto-bi-femoral 
graft) 
? Graft-enteric erosion 
? Graft-enteric fistula 
? Aortic stump sepsis after excision of an infected aortic graft 
Since diagnosis, management and prognosis are somewhat different in case of a graft 
infection compared to a graft-organ erosion or a fistula and aortic stump sepsis; they are 
being considered rather as different entities and not as secondary graft infections (Bunt 
1983). Szilagy’s classification was commonly used during earlier years, while latest 
recommendations regarding AGIs favour classifying infections as early or late, based on 
time gap from index operation. Modified Bunt’s classification is used to report the extent 
of AGI and presence of complications (Tebeeken et al 2012). 
??? ?????????????
????? ?????????
1.3.1.1 Biomolecular level 
As a foreign body, an aortic prosthetic graft is more susceptible to infection than 
autologous tissue. Alloplastic implant is a suitable microenvironment for bacterial 
adhesion and small inoculum is enough to seed the implant (Elek and Conen1957). Blood 
and tissue fluid proteins facilitate the subsequent adhesion by providing adhesion matrix 
molecules on the surface of the vascular graft (Frei et al 2011). When microorganisms 
convert from free-floating to adherent form and start multiplying, the attachment to 
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prosthesis becomes stronger. Firmly anchored bacteria change genetic transcription to 
up-regulate virulence markers, start secreting extracellular polymers and recruit other 
pathogens. Biofilm forms via cell division and recruitment offering protection to viable 
microorganisms against the host defence system and antibacterial agents. (Hall et al 
2014.) Biofilm may develop in a fast or slow flow environment and is dependent of the 
porosity of the graft. Knitted and woven Dacron grafts have higher porosity and are 
therefore more susceptible to bacterial adhesion and protein deposition than expanded 
polytetrafluoroethylene (PTFE) grafts. Mature biofilm includes dormant bacteria and 
dispatchable mobile cells in a planktonic condition to be spread through the vascular tree, 
create new microcolonies and thereby spread the infection. (Schmitt et al 1986, Woźniak 
et al 2017.) On the graft surface spreading of biofilm is slow and damage to graft material 
minimal but close to the area of graft-to-artery anastomosis, the tensile strength of artery 
can be reduced and a pseudoaneurysm may form. Invasion from graft surface to perigraft 
tissue to develop a fulminant sepsis is uncommon in case of low-virulent bacteria due to 
slow growth and sparse planktonic release and bacterial samples from perigraft liquid 
may therefore yield negative results (Frei et al 2011).  
Bacterial invasion, biofilm formation and planktonic release are irritating to the host, 
causing an immune response. First reaction to bacterial invasion comes from neutrophils 
and is followed by reaction from macrophages. They circulate in blood and are attracted 
to the infection site by chemotactics to eliminate bacteria by phagocytosis and 
intracellular killing. Introduction of a foreign body attracts polymorfonuclear cells (PMN) 
and may activate phagocytosis. As has been shown with PTFE material, frustrating 
phagocytosis of nonphagosytosable material leads to partial exhaustion of PMN function, 
and loss of bactericidal activity already in an hour. Therefore, this locally acquired 
phagocytic defect has been shown to diminish PMN-mediated protection against 
staphylococcal strains and may be one factor contributing to biofilm generation and graft 
infection. (Zimmerli et al 1984.) Biofilm bacteria attach to graft material with minutes, 
connection becomes firm within 2-4 hours and secretion of protective matrix starts. This 
microenvironment makes biofilm bacteria recalcitrant to antibody reaction and 
phagocytosis considerably fast. However, albeit immune system cannot eliminate the 
invader, it remains stimulated. This chronic immune response attenuates incorporation 
of vascular prosthesis to surrounding tissue and causes autolysis of perigraft tissue. (Frei 
et al 2011, Hall et al 2014, White and Hollier 2008.)  
Chronic inflammatory response is also induced by implanted vascular graft to isolate the 
foreign body from adjacent tissue by encapsulating it with fibrous collagen tissue. 
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Mononuclear cell infiltration, angiogenesis, capillary ingrowth, fibroblast proliferation and 
collagen deposition will incorporate vascular graft into surrounding tissue. Any factor 
undermining this process (seroma, haematoma, etc.) will attenuate graft incorporation as 
well as luminal endothelisation. Platelets, fibrin and a thin thrombus will be first to line the 
luminal surface of implanted vascular graft. Near anastomosis, endothelial cells, smooth 
muscle cells (SMC) and fibroblasts will migrate from the adjacent artery to create 
endothelial surface – however, luminal migration can only cover limited distance. It is 
postulated that stable endothelialisation of the full length of the prosthesis requires 
capillary ingrowth of porous material, since endothelium has been found absent in areas 
with no tissue incorporation. The lack of luminal endothelia makes graft more 
thrombogenic and serves attachment sites for bacteria spreading haematogenous ways. 
(Moore et al 1980, Berger et al 1972, Zdanovski et al 1994, Lejay et al 2017*.)  
Insertion of vascular graft causes local tissue damage with ischaemic and acidic 
conditions around the perigraft area. Neutrophils continue to phagocytise in acidic 
environment, but local tissue hypoxia can hinder their function. Foreign body diminishes 
PMN activity and bactericidal function. With the addition of local autolysis due to immune 
response, the perigraft area becomes an excellent breeding ground for bacteria making 
it easy for infection to spread along graft surface. (Bergamini et al 1994.) 
According to United States National Institute of Health’s public announcement, biofilms 
account for over 80% of human microbial infections. In case of vascular prosthetic 
infection, presence of biofilm challenges the conservative treatment of AGI and, 
therefore, graft explantation is required for eradication (Frei et al 2011). 
 
1.3.1.2  Evolution of infection and associated risk factors 
Bacteria or fungi can seed vascular graft in four different ways: perioperative 
contamination, haematogenous seeding by bacteraemia, mechanical erosion of the skin, 
genitourinary or gastrointestinal tract, or involvement in adjacent infectious process.  
It is generally accepted that usual time of graft contamination is during the operation. It 
can be caused by direct contact with bacteria through skin incision, since skin and lymph 
nodes are a reservoir of bacteria, or there may be a breakdown in aseptic. Bacterial 
spread can be haematogenous or lymphatic from remote sites of infection, or micro-
organisms located in arterial wall or intramural thrombus can be a potential cause for 
AGI. (Cornenwett and Johnston 2010.) 
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Contamination 
Most frequent sources of infection are endogenous pathogens from patients’ skin. 
Staphylococci can contaminate the graft through the direct contact between graft and the 
skin or after excessive and reckless graft handling. Bacteria can also harbour in deeper 
dermal layers, scar tissue and sweat glands, where they remain relatively unaffected by 
topical bactericidal agents (Hicks and Greenhalgh 1997). Recent previous percutaneous 
arterial access or surgery may elevate the risk of graft contamination probably due to 
introduction of skin flora into subcutaneous tissue and local haematoma. 
Positive bacterial samples from arterial wall have been considered to be a risk factor for 
graft infection. Routine samples form arterial reconstructions may yield positive results in 
up to 43% of the cases with Coagulase-negative staphylococci (CNS) as most prevalent 
culprit, but direct correlation with AGI is lacking (Durham et al 1987). However, in case 
of redo surgery, correlation between positive samples and subsequent graft infection has 
been suggested (Durham et al 1987, White and Hollier 2008). Any reoperation carries a 
risk of bacterial contamination, including secondary procedures for treating the 
endoleaks following EVAR (Hobbs et al 2010). In case of mycotic aneurysms, the 
association with wall bacteria and graft infection is clear (Sörelius et al 2014). 
Laminar ventilation has reduced the problems with airborne bacteria in operating rooms, 
but the risk for infection is higher with endografts implanted in interventional radiology 
suites (Ducasse et al 2004). Accidental opening of genitourinary or gastrointestinal tract 
can predispose the graft to contamination with endogenous bacteria (Cornenwett and 
Johnston 2010, Capoggia et al 2016). Furthermore, aseptic breakdown in surgical 
technique can be an infection source, particularly in case of emergency, in addition to 
extended operation time (Cheng et al 2017). 
 
Bacteraemia 
Haematogenous seeding is a rare but important mechanism. Concomitant infection is a 
risk factor for AGI. Bacteria can be transmitted from vascular catheters or during 
bacteraemia from remote infection sites such as urinary tract infections, pneumonia or 
cellulitis. (Cornenwett and Johnston 2010.) Perioperative graft colonisation has 
decreased after introduction of parenteral antibiotic prophylaxis, but exposed surface of 
foreign material remains attractive attachment site to haematogenous bacteria in early 
postoperative period. Graft incorporation and growth of endothelial layer during the later 
period will diminish susceptibility to infection, although complete endothelialisation may 
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never happen resulting in graft’s vulnerability. (Moore et al 1980.) An occult low-grade 
infection may deny graft incorporation and endothelialisation, allowing virulent bacteria 
during future episodes of bacteraemia to inoculate prosthetic graft surface and convert 
the low-grade infection to a symptomatic AGI. Therefore life-long antimicrobial 
prophylaxis should be considered to patients with aortic prosthetic reconstructions in 
case of invasive procedures with transient bacteraemia. (Cornenwett and Johnston 
2010.) 
 
Mechanical erosion 
Erosion of aortic graft through the skin or to gastrointestinal tract often occurs due to a 
low-virulent infection. However, as a result of the fistulation, superinfection with more 
virulent bacteria may develop systemic infection.  
An aorto-enteric fistula and erosion are a communication between aortic prosthetic graft 
and adjacent intestine. Most commonly third part of duodenum becomes involved due to 
its relatively fixed position and proximity to aortic graft body. Constant pulsatile 
movements of noncompliant graft can cause mechanical microtrauma and secondary 
ischaemia to duodenum when intervening soft tissue in retroperitoneal area is missing. 
A fistula usually develops after anastomotic pseudoaneurysm formation due to a low-
grade infection or fatigue. Pseudoaneurysm can erode into the intestine and create a 
communication between aorta and intestine. In case of erosion, mechanical trauma to 
duodenum is the cause and graft contamination with enteric bacteria the result. However, 
the infection can spread in paraprosthetic tissue, involve anastomotic areas and result in 
pseudoaneurysm formation or rupture as well. (Omara et al 1981, Bunt 1983, Cornenwett 
and Johnston 2010.) 
AEF development after EVAR is rare and often associated with a persistent endoleak 
and aneurysm growth or endotension (Spanos et al 2017). 
A non-septic graft-cutaneous fistula is usually associated to low-grade streptococcal 
infection, causing chronic inflammation and tissue autolysis (Bergamini et al 1994).  
 
Extension of contiguous infection focus   
Wound healing complications are a risk factor for an AGI. Meticulous surgical technique 
with skin apposition and proper haemostasis will promote prompt fibrin seal, but 
excessive use of electrocautery and extended application of wound retractors can cause 
extensive skin and soft tissue trauma, resulting in large tissue necrosis. Presence of 
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wound haematoma or fatty necrosis diminishes the inoculum required for developing a 
wound infection and facilitates the extension of superficial infection to subcutaneous 
tissue and graft. Operating in scar tissue and obesity raise the risk of wound 
complications. (Inui and Bandyk 2015.) Colonisation in retroperitoneal space due to 
diverticulitis, periappendicular abscess, discitis or lumbar osteomyelitis has been 
described (Perera et al 2014, Laser et al 2011). 
 
Patient-related risk factors 
Any condition impairing host defences makes patient more susceptible to AGI. 
Deprivation of host immune reaction due to malnutrition, malignancy, chronic end-stage 
renal disease, long-term corticosteroid treatment, antirejection on cytostatic 
medicaments, lymphoproliferative disease or autoimmune disorders will diminish the 
amount of inoculation necessary to develop an AGI (Cornenwett and Johnston 2010).  
Obesity is a risk factor for wound infection and subsequently possibly to graft 
contamination. Surgical intervention disturbs the fine balance between fat lobules and 
capillary system, leading to relative vascular insufficiency and diminished oxygen supply. 
This results in decreased collagen synthesis, decreased oxygen-dependent capacity to 
eliminate bacteria, and decreased ability to support the mechanisms of healing process. 
(Anderson and Hamm 2012.) Wound care proposes challenges in humid skin creases 
and diminishes the local oxygen supply even further.  
Diabetes has been considered to be a risk factor for infections by attenuating host 
immune defence. The presence of hyperglycaemia constantly activates PMNs, making 
them less responsive to infectious stimuli. Diabetics as well patients with end-stage renal 
disease are more likely to be hospitalised and colonised with more virulent hospital-
acquired bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). (Dryden 
et al 2015) Prolonged preoperative hospital stay is yet another risk factor for AGI.  
 
????? ?????????????
The most common isolated bacteria in AGI are Staphylococcal strains. Staphylococcus 
aureus is the most prevalent isolated microorganism accounting for more than quarter of 
all infections, but the proportions of Staphylococcus epidermidis and gram-negative 
bacteria are on the rise (Chambers 2005). The spectrum of bacteria varies depending on 
the time of infection onset after index operation and clinical presentation, but the 
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proportions follow along the lines of the reported microbial epidemiology of vascular 
prosthetic graft infections: Staphylococcus aureus, 20 %–53%; Enterobaceriaceae, 
14%–41%; Coagulase-negative staphylococcus, 15%; Pseudomonas aeruginosa, 
Streptococcus spp and Enterococcus spp, 10%–15%; polymicrobial infections, 20%; 
obligatory anaerobes, 5% and Candida spp, 1%–2% (Revest et al 2015). However, 
prevalence of polymicrobial and candida infections is probably higher in case of AGI due 
to an AEF.  
Early perigraft infections are commonly caused by more virulent bacteria acquired via 
perioperative contamination or haematologically during the postoperative period: S.  
aureus, MRSA, Escherichia coli, Pseudomonas, Proteus and Kleibsiella. Coagulase-
negative staphylococci are common in late perigraft infections; however, they can play a 
part in the polymicrobial growth when indolent Staphylococcus epidermidis persistence 
becomes complicated by virulent superinfection. AEE and AEF present rather as late 
infections and commonly have polymicrobial etiology. (Cornenwett and Johnston 2010.)  
Staphylococci infections are typically result of perioperative contamination. S.  
epidermidis is a coagulase-negative skin commensal, which is strongly adherent to 
foreign bodies. Perioperative graft colonisation leads to biofilm formation where S. 
epidermidis can remain indolent for years. Due to low virulence, it is not capable of tissue 
invasion, but chronic host immune system stimulation can lead to tissue autolysis with 
perigraft fluid collection, graft-cutaneous fistula, anastomotic pseudoaneurysm or graft 
limb thrombosis. (Bandyk et al 1991, Hicks and Greenhalgh 1997.) Determining a S. 
epidermidis infection is challenging, as perigraft fluid and tissue commonly yield negative 
results. Sonication of prosthetic material is the most sensitive method to reveal bacterial 
growth, but it is unfortunately strongly underused in clinical practice (Chambers 2005). 
Another member of normal skin flora, Staphylococcus aureus, is a virulent bacterium 
often accountable for wound infections and early AGI. S. aureus produces mucinous 
biofilm to promote its adhesion to the prosthetic material and to protect itself against host 
defensive mechanisms and antibiotics. It is aggressively invasive pathogen, producing 
variety of toxic proteolytic enzymes and coagulase, which cause haemolysis, cell 
necrosis, autolysis and widespread inflammatory process. (Hicks and Greenhalgh 1997, 
Chiesa et al 2002.) 
Among gram-negative rods, which are generally more virulent than gram-positive rods, 
Pseudomonas aeruginosa is a microorganism that causes complicated nosocomial 
infections. Taking advantage of immunocompromised situation, it spreads rapidly 
causing tissue invasion and sepsis. Pseudomonas produces elastase, alkaline protease 
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and endotoxins, which can break down elastin, collagen and fibrin, leading to tissue 
necrosis. Both, Pseudomonas and Staph. aureus typically cause acute systemic infection 
with rupture of anastomosis and haemorrhage. (Hicks and Greenhalgh 1994, Chiesa et 
al 2002, Perera et al 2006.) In addition to disseminative infection, Pseudomonas can 
create a protective biofilm keeping host immune response alert. As the immune system 
is unable to eliminate biofilm bacteria, the host tissues are damaged. Surrounding tissue 
becomes exposed to oxidative radicals and lytic enzymes released from inflammatory 
cells.  Host cell release of proteases and elastases also degrades the immune cells and 
diminishes the anti-biofilm reaction even further. Therefore, pseudomonas infection 
remains highly resistant to conservative treatment and favours aggressive surgical 
interventions. (Moser et al 2017.)  
At the beginning of the 21st century, the prevalence of vascular graft infections caused 
by methicillin-resistant Staphylococcus aureus (MRSA) was approximately 30%–40% 
(Hodgkiss-Harlow et al 2011). Since then, the prevalence has steadily declined in Europe 
but remains at >20%. Albeit skin colonisation among general population is 2%, it is 
significantly higher among people in long-term care facilities and with chronic ischaemic 
wounds (9%–22%) (Manzur and Gudiol 2009). There is an increased risk of amputation 
and prolonged length of hospital stay among patients with MRSA, and morbidity and 
early mortality are also higher with MRSA infection (Hodgkiss-Harlow et al 2011, Inui and 
Bandyk 2015, Revert et al 2015). 
Candida spp, Mycoplasma and Mycobacterium as monoinfections are more prevalent 
among patients with immunocompromised condition. However, long-lasting antimicrobial 
treatment can provoke yeast overgrowth and graft superinfection. Furthermore, patients 
presenting with AEE/AEF may have Candida as a co-infection. (Cornenwett and 
Johnston 2010.) 
In one third of the cases bacterial growth from an explanted graft or perigraft tissue 
remains negative, although there is a clinically and radiologically confirmed AGI. S. 
epidermidis and fungal infections are challenging to isolate, but antimicrobial treatment 
has often been administered prior to sample acquisition and, therefore, bacterial 
cultivation may no longer be successful (Kieffer et al 2004, Chambers 2005). 
 
??? ???????????
Since surgical site infection (SSI) is a major risk factor for subsequent graft infection, 
measures to prevent SSI should be taken: bathing on the evening before operation, hair 
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clipping only immediately before the operation if necessary, skin preparation with alcohol-
based antiseptics, prophylactic antibiotics, meticulous surgical technique, perioperative 
blood glycose control, tissue oxygenation and normothermic body temperature, as well 
as triclosan-coated sutures (Edmiston et al 2014, Inui and Bandyk 2015, Global 
Guidelines for SSI 2016).  
Meticulous postoperative wound care and leaving sterile wounds undisturbed for 24–48 
hours, as well as aggressive local, antibacterial or even surgical treatment when signs of 
skin edge necrosis, infection or excessive lymphatic drainage appear, are common 
preventive methods of SSI (Inui and Bandyk 2015, Hodgkiss-Harlow et al 2011). 
Prophylactic negative-pressure wound treatment (NPWT) has emerged as a wound 
dressing that decreases SSIs and subsequent AGIs. Tightly sealed and uninterrupted for 
several days, the dressing prevents local contamination. The negative pressure applied 
keeps wound dry and diminishes dead space possibly leading to a faster wound healing. 
In a retrospective study including 115 patients, prophylactic NPWT diminished SSI-rate 
in groin area to 3% compared to 30% in non-NPWT group (Matatov et al 2013). 
Retrospective data seems to favour routine use of NPWT but results from randomised 
controlled trials (RCT) are still missing. 
Remote infection focuses should be treated prior to the operation and sufficient healing 
time provided. However, if aortic prosthetic grafting is urgent, pre- and postoperative 
parenteral antimicrobial treatment based on susceptibility should be administered. 
(Cornenwett and Johnston 2010.)  
Antibiotic prophylaxis must be administered prior surgery. In vascular prosthetic surgery 
dual therapy with first- or second-generation cephalosporine in combination with a 
glycopeptide (eg vancomycin) is used. Glycopeptide should be administered 60–120 
minutes before the incision, since drug distribution in tissue and appearance of 
bactericidal activity is slow. Cephalosporines should be administered 30 minutes before 
operation and redosed if procedure lasts over three hours or blood loss exceeds 1.5 
litres. There are no recommendations about postoperative prolongation of antibiotic 
prophylaxis, but some prefer prolonged antimicrobial parenteral medication until intra-
vascular catheters and tubes are removed or when two or more patient-dependent risk 
factors are present .(Cornenwett and Johnston 2010, Hodgkiss-Harlow et al 2011, Inui 
and Bandyk 2015, Global Guidelines for SSI 2016.) 
The application of silver-impregnated or rifampicin-soaked grafts prophylactically has 
been studied widely. Silver ions bound to vascular grafts may affect Staphylococcal 
strains, E. coli and Pseudomonas aeruginosa by deactivating their enzymes, damaging 
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their cytoplasmic membrane, causing oxidative stress, and reducing their growth and 
division. Antibacterial effect is stronger against Gram-negative strains, possibly due to 
the thicker cell wall of gram-positive strains. (Quing et al 2018) Silver-acetate also 
promotes graft ingrowth to surrounding tissue, diminishing the possibility of perigraft 
seroma and subsequent bacterial contamination. In vivo testing on animals has shown 
the benefit of silver-acetate in tissue-incorporation over vaporized silver application to 
the Dacron grafts. The release of vaporized silver can last up to 12 months and eventually 
slow down the incorporation, as opposed to the quick release of silver-acetate that only 
lasts for 2–3 weeks. (Jeanmond et al 2013 and 2014) Nevertheless, in retrospective 
study with 913 patients, the prophylactic use of silver-acetate grafts has not shown 
significant benefit over common Dacron graft to justify routine use in infection prevention 
(Larena-Avellaneda et al 2009). 
Rifampicin-bonded grafts have been used prophylactically and in case of infectious 
conditions. Two randomised controlled trials have been published with 600 patients form 
Italy and 2610 patients from a European multicentre study. All of the procedures included 
in the Italian study were aorto-femoral or iliac-femoral reconstructions with an inguinal 
incision, while the European study also included aorto-iliac reconstructions. Both found 
no significant differences between the two study groups in case of AGI, however, 
European study found significantly fewer wound infections (Szilagy I–II) in rifampicin-
group compared to bare prosthesis. (D’Addato et al 1997, Goëau-Brissonnière et al 
2011.) A late in vitro study by Berard showed that impregnated rifampicin loses its anti-
staphylococcal efficacy relatively fast and bonded grafts may lead to emergence of 
rifampicin-resistant staphylococcal strains compromising the future efficacy of this 
antibiotic (Berard et al 2018). The high-concentrations used for soaking Dacron grafts to 
bond an effective amount of rifampicin have revealed to be toxic to endothelial and other 
vascular cells (Herten et al 2017). Therefore, prophylactic use of rifampicin-bonded grafts 
cannot currently be recommended either.  
 
??? ??????????
Until recently, AGI diagnosis was based on various combinations of patient symptoms, 
biochemical markers and radiological studies, making it impossible to distinguish 
between suspected and confirmed cases in the literature. To homogenize the AGI 
population and to make the data more comparable between different institutions, the 
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Management of Aortic Graft Collaboration suggested combination of diagnostic criteria 
to define the suspicion and confirm the diagnose of AGI (Lyons et al 2016).  
After a systematic review of literature, the collaboration reached a consensus to define 
an AGI based on diagnostic criteria grouped as clinical, radiological or laboratory criteria 
(Figure 1). One major criterion or two minor criteria from different is regarded as a 
suspicion of AGI. An aortic graft infection can be diagnosed when, in addition to one 
major criterion, any other criterion from another category is present. If low-virulent skin 
commensals (eg coagulase-negative staphylococci, proprionbacerium etc.) are cultured, 
the same bacteria must be confirmed in another intraoperative specimen and/or blood 
cultures to exclude contamination. (Lyons et al 2016.) 
 
Figure 1 Major and minor criteria for suspecting and diagnosing an aortic graft infection. CT, 
computed tomography; FDG PET, fluorodeoxyglucose positron emission 
tomography; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein. 1 
                                                 
1 Lyons OT et al. Diagnosis of Aortic Graft Infection: A Case Definition by the Management of Aortic Graft Infection Collaboration 
(MAGIC). Eur J Vasc Endovasc Surg. 2016 Dec; 52:758-763. DOI: 10.1016/j.ejvs.2016.09.007. Published by ELSEVIER Inc. 
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License 
(https://creativecommons.org/licenses/by-nc-nd/4.0/)?
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The non-specific nature of the AGI symptoms often delays the diagnosis and postpones 
adequate treatment. High index of suspicion is required to commence radiological 
studies and distinguish an AGI from other medical conditions. Berger conducted a 
questionnaire study among members of the Dutch Society of Vascular Surgery about 
diagnostics and treatment of AGI. The results showed that despite a highly variable 
clinical picture, 40% of surgeons consider fever early after graft implant to be an integral 
part of AGI as well as groin infection, while 95% rely on the results of radiological studies. 
(Berger et al 2015.) EVAR infections are predominantly highly symptomatic, however 
10% of low-grade infections are detected during routine follow-up imaging. High 
suspicion is necessary for early detection due to completely intracavitary location 
.(Argyriou et al v2017.) 
High-virulent bacteria are more common in early infections, presenting with aggressive 
symptoms such as high fever, sepsis and abdominal or back pain. Sepsis and fever are 
the most common symptoms (43%–70%) referring to an abscess in the groin or 
intracavitarily in 24%–37% of cases (Keiffer et al 2004, Daenans et al 2003, Davila et al 
2015). Frequently present groin sinuses (26%–43%) or femoral pseudoaneurysms 
(18%–36%) are more typical for low-grade infections or aorto-enteric erosions (Kieffer et 
al 2004, Daenans et al 2003, Ali et al 2009). 
Low-grade infections are typically caused by low-virulent bacteria, appear later and 
present with vague symptoms – general malaise, weakness, weight loss or anorexia. 
Graft thrombosis, gastro-intestinal bleeding, erythema over the graft, and cellulitis are 
symptoms associated with AGI and possible AEF or AEE.  
AEF and AEE, as the most challenging clinical situations, represent roughly one third of 
AGI cases and often appear as haematemesis, melaena or anaemia. More than half of 
these patients experience herald bleeding characterised by intermittent haemorrhage 
and clot formation to the fistula. Gastrointestinal (GI) bleeding with a history of aortic 
reconstruction should urgently lead to further investigations; nevertheless, 21%–31% of 
then patients arrive in hospital in haemorrhagic shock. In case of erosion, sepsis is more 
common, frequently in combination with a groin abscess. Proximal anastomotic 
pseudoaneurysm as a contributing factor for fistulation is found in up to 46% of the cases. 
Abdominal and back pain are typical accompanying symptoms due to inflammation, while 
graft thrombosis and septic embolisation are rather infrequent. (Bergqvist and Björck 
2008, Batt et al 2011, Oderich et al 2011)  
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Completely intracavitary aortic endograft infections present as sepsis or an AEF. Despite 
total intraluminal location, AEF is still common representing 31%–48% of cases. In 
contrast to the sequelae of open surgery, the fistula in cases of an endograft almost 
invariably forms between the fourth part of duodenum and the aneurysm sac (Hobbs et 
al 2010). Two thirds of all septic infections are high-grade, with a fever of > 38 degrees 
centigrade and abdominal pain, and the remaining third constitute low-grade infections 
with non-specific chronic symptoms. (Ducasse et al 2004, Hobbs et al 2010, Chaufour et 
al 2017.)  
 
????? ????????????????????
 Elevated leukocyte count, erythrocyte sedimentation rate (ESR) and C-reactive protein 
(CRP) as inflammatory markers are common, but not pathognomonic of AGI. Abnormal 
CRP values among patients with confirmed AGI have been reported, with a mean value 
of 96?79 mg/L in all patients and leucocytosis of >11x109/L in 63% of patients (Lyons et 
al 2014, Garot et al 2014, Davila et al 2015). CRP is elevated during the postoperative 
period and therefore not indicative of an early AGI. In case of normal inflammatory 
biomarkers and peripheral leukocyte count, however, AGI is unlikely. Inflammatory 
markers may indicate the severity of infection and are useful tools in evaluation of 
treatment effectiveness and in follow-up (Wilson et al 2016). 
Positive blood cultures can be obtained from 52%–53% of the patients, and overall 
positive bacterial cultures from 55%–83% of patients, 23%–43% of which are typically 
polymicrobial (See section 1.3.2 Bacteriology for details) (Ali et al 2009, Hobbs et al 2010, 
Bisdas et al 2010, Batt et al 2011, Kahlberg et al 2016, Garot et al 2014). Bacterial swabs 
from draining sinuses may reveal true pathogens, but in case of low-grade infection, 
cultured skin commensals may indicate contamination. Perigraft fluid aspirates, 
organisms recovered from an explanted graft, or perigraft tissue have strong diagnostic 
value when true pathogens are isolated. When aspirate shows leukocytes only and tissue 
samples remain negative, results could be improved with sonication, in addition to broad 
range polymerase chain reaction (PCR) and bacterial DNA sequencing. (Perera et al 
2006, Lyons et al 2016.) 
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Due to the nonspecific clinical symptoms, diagnosis of AGI relies on radiological studies, 
providing information on the extent and specifics of infection and enabling the planning 
of the possible surgical reconstruction.  
1.5.3.1 Computed tomography angiography 
CT is the gold standard in diagnosis of AGI. It is fast, easy to perform, easily accessible, 
and it provides sufficient data on vascular tree and adjacent structures when intravenous 
contrast media is used.  Perigraft fluid, gas, soft-tissue oedema, pseudoaneurysms and 
focal bowel wall thickening can be distinguished with computed tomography angiography 
(CTA) with specificity of 85%–100%; however, the sensitivity varies between 78% and 
94% and is lower in early infections. (Fiorani et al 1993, Orton et al 2000) Early 
postoperative period is a challenge to every radiologic study as regards distinguishing 
between a normal postoperative environment and an infection. However, perigraft fluid 
persisting over 3 months and perigraft air persisting over 7 weeks are suspicious to an 
infection (Qvarfordt et al 1985, Lyons et al 2016). Scintigraphy studies and MRI may offer 
more information, but correlation with clinical and laboratory signs define the course of 
action. CT-guided aspirations can be performed in diagnostics, but if they are revealed 
to be negative, a series of CT scans over few years are recommended. In rare cases, 
perigraft fluid has been observed for up to one year without graft infection. (Orton et al 
2000.) AEF can often be diagnosed from CTA scans during the later postoperative 
period; the sensitivity is very high, but not the specificity. Patients with AEF frequently 
present with disappearance of periaortic fatplane and fatplane between aorta and bowel, 
as well as excessive perigraft soft tissue, focal bowel wall thickening adjacent to the graft, 
perigraft fluid and ectopic gas, pseudoaneurysms and dystrophic vascular graft 
calcifications (Figure 2). Active extravasation into the bowel and graft location inside the 
bowel lumen are pathognomonic signs of AEF. (Hagspiel et al 2007.) Endoscopic studies 
can be performed in case of uncertainty to identify graft material in the bowel, mucosal 
erosions or intruding pulsatile mass. However, the specificity of gastroduodenoscopy is 
lower compared to CTA – 57% vs 79%, respectively (Deijen et al 2016). An additional 
benefit of CT is the detection of other conditions occasionally present with AGI, such as 
more remote abscesses, discitis and osteomyelitis or hydronephrosis (Orton 2000).  
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1.5.3.2 Magnetic resonance imaging  
MRI has not been used as widely as CT in the diagnosis of AGI. MRI is more sensitive 
to smaller amounts of liquid and allows differentiation between perigraft fluid with 
inflammatory changes in surrounding tissue eg psoas muscle and chronic haematoma.  
However, it cannot differentiate between infected and sterile liquid in early postoperative 
phase, nor identify AEF, unless surrounding inflammation is present. (Olofsson et al 
1988.) The specificity and sensitivity of MRI in diagnosis of an AGI have been reported 
to be 97% and 68%, respectively. Compared to Indium-111-labelled white blood cell 
scans, the diagnostic value is similar (87% and 73%, respectively) and in case of 
incomplete CT results, MRI therefore could be preferred, as it is less invasive and does 
not cause radiation exposure. (Shahidi et al 2007, Bryggink et al 2011.) 
 
 
 
Figure 2 Aorto-enteric fistula. A) Pseudoaneurysm and disappeared fatplane between the 
intestine and an infectious aneurysm sac. B) Gas inside the abscess around a 
pseudoaneurysm. 
1.5.3.3 Nuclear medicine techniques 
 18F – FDG-PET/CT 
Fluorodeoxyglycose (FDG) is a radioactively labelled glucose uptaken by metabolically 
active leukocytes aggregating to the graft surface in case of an AGI. Metabolic activation 
is detected by positron emission tomography (PET) and anatomic lesions located with 
Review of the Literature 
31 
CT. The integration of anatomic and metabolic locations improves the interpretation of 
results and helps to differentiate AGI from other infections and physiologically abnormal 
uptakes. Diffuse or linear FDG uptake on a PET scan is characteristic of inflammation, 
and focal uptake is rather suggestive of infection, but diagnostic problems are caused by 
false-positive results. (Saleem et al 2015) Fusion scans have improved results, and 
Spacek reported positive predictive value of 97% and negative predictive value of 95% 
with focal uptake; however, with diffuse uptake, positive predictive values dropped to 
77% (Spacek et al 2009). Chang hypothesised that metabolic cells in inflammation might 
have different tracer release pattern to those in an infectious environment and performed 
a second scan 45 minutes later. Positive predictive value among 29 patients was 100%, 
but negative predictive value remained at 72% with the second scan added. (Chang et 
al 2015.)  
 
Leukocyte scintigraphy 
Radiolabelled leukocytes with Indium-111 or Technetium-99m can be used to identify 
infection focus, since radioactive label is tagged to neutrophils. In-111-scans have been 
reported to have sensitivity of 73% and specificity of 87%; Tc-99m-scans a sensitivity of 
79%–100%, and specifity of 83%–100% (Keavey et al 1991, Prats et al 1993, Fiorani et 
al 1993, Shaidi et al 2007). In-111-scans take over 24 hours to yield results, their 
accuracy is low in low-grade infections and during the early postoperative period. Tc-
99m-scans can be read in 4 hours after leukocyte reinfusion and seem to be more 
accurate in early and low-grade infections. Tc-99m-scans were performed on 20 patients 
during the first and second postoperative week after aortic reconstructions in a study by 
Keavey. During the first week, there were 14 negative, 2 positive and 4 ambiguous 
results, during the second week 18 negative and 2 ambiguous results. One unclear result 
turned negative during the third week. Overall specificity was 83%, but for the studies 
taken after the first week, it was 95%. (Keavey et al 1991.) In case of low-grade infection 
and negative CT scan, a tc-99m scan performed better with sensitivity of 100% and 
specificity of 94%, as well as positive and negative predictive value of 95% and 100%, 
respectively (Fiorani et al 1993). 
Single-photon emission CT (SPECT/CT) is a more advanced, three-dimensional 
information-producing tagged leukocyte scan that seems to produce the highest 
accuracy in case of vascular graft infection (Reindels Formel et al 2018).   
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However, due to poor access, high dose of radiation, time consuming imaging, lack of 
extensive experience and conclusive data, as well as high cost, nuclear medicine 
techniques remain complementary studies when results of standard CT are inconclusive.  
 
? ??????????????????????????????????
??? ????????????
Mycotic aortic aneurysm is a misleading term, but currently used for all aortic aneurysms 
with infectious origin. Sir William Osler was the first to describe a mycotic aortic aneurysm 
in Gulstorian lectures as septic embolic complication of endocarditis. Osler described a 
man diagnosed with syphilis who died after suffering diarrhoea, headaches, chills and 
fever. Autopsy revealed 4 irregular thoracic aortic aneurysms, one of which had “fresh 
fungous vegetations” and was ruptured to the pericardial sac (Osler 1885). In 1923 
Stengel showed that an infected aneurysm may develop as a result of other septic 
conditions without valvular vegetations, and Sommerville described 6 cases of ruptured 
infected aneurysms with previous atherosclerotic changes, linking atherosclerotic arterial 
wall damage to a susceptibility to bacterial attachment (Stengel and Wolferth 1923, 
Sommerville et al 1959). After introduction of antibiotics and recognition of the use of 
aggressive surgical interventions on such aneurysms, the incidence of mycotic 
aneurysms declined (Barker 1953, Brown et al 1984, Trairatvorakul et al 1990, 
Cornenwett and Johnston 2010).  
In current literature, mycotic arterial aneurysm and arterial infection are used 
synonymously, and both are therefore also used in the present thesis Despite being a 
misnomer, mycotic arterial aneurysm is a comprehensive term encompassing 
aneurysms that emerge after bacterial seeding an arterial wall, as well as previously 
existing atherosclerotic aneurysms with secondary infection. Clinical course of such 
aneurysms is considerably fast, and patients typically present with abdominal pain, fever, 
elevated infection markers and an eccentric or saccular aneurysm in CT scan.  
 
??? ???????????????
The classification of a mycotic arterial aneurysm is based on etiology and was reported 
by Wilson in 1978 after several definitions had emerged in the literature. He divided 
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arterial infections into four subgroups based on their clinical features: mycotic aneurysms 
caused by cardiac emboli; infected aneurysms and secondary infections of pre-existing 
aneurysms; microbial arteritis as haematogenic infection of non-aneurysmatic arteries 
and infected pseudoaneurysms caused by trauma, such as puncture (Wilson et al 1987). 
In addition, an infected aneurysm can develop secondarily to contiguous spreading of 
adjacent infection such as pancreatitis – however, due to the local spreading, the 
pathophysiology of wall damage is not bloodborne nor intima-mediated.  
Primary aorto-enteric fistulas remain beyond the scope of current thesis and are therefore 
not discussed further herein. 
Table 1. Classification based on the clinical features of infected aneurysms according to 
Wilson et al 1987.2 
 
In the latest review of nomenclature, Sörelius suggested another subdivision to be added 
to classification, namely – HIV-related aneurysms (Sörelius et Di Summa 2018).  
 
                                                 
2 Wilson SE et al. Arterial Infection. Curr Probl Surg. 1978 Sep;15:1-89. Published by ELSEVIER Inc. Creative Commons 
Attribution-NonCommercial-NoDerivatives 4.0 International Public License (https://creativecommons.org/licenses/by-nc-nd/4.0/) 
?
 
 
Mycotic 
Aneurysm 
Infected 
Aneurysm 
Microbial  
Arteritis 
Post-traumatic 
Infected False 
Aneurysm 
Etiology Endocarditis Bacteraemia Bacteraemia Trauma, drug 
addiction 
Age 30–50 yrs >50 yrs >50 yrs <30 yrs 
Incidence Rare Unusual Common Common 
Number Multiple Single Single Multiple 
Location Aorta 
Visceral 
Intracranial 
Peripheral 
Infrarenal Aorta Aortoiliac 
Femoral 
Previous 
Intimal defects 
Femoral Carotid 
Bacteriology Gram-positive 
cocci 
Staphylococcus 
E.coli 
Salmonella 
Others 
Polymicrobial 
Mortality  25% 90% 75% 5% 
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??? ??????????????
????? ?????????????????????????????????????
Healthy arterial luminal wall with an uninterrupted intimal layer is resistant to bacterial 
invasion. However, any clinical situation causing intimal damage, such as 
atherosclerosis, (syphilitic) arteritis or cystic media necrosis, may create an attachment 
site for bacteria and manifest as a mycotic aneurysm (Wilson et al 1952, Sommerville et 
al 1959, Jackman and Radolf 1989).  
 
2.3.1.1 Mycotic aneurysms 
A mycotic aneurysm arises, when septic an embolus from heart valve vegetations 
dislodges into the vasa vasorum of great vessels or lumen of smaller peripheral vessels. 
In the aorta and iliac vessels, large vasa vasorum arise from the site of the side branches 
and continue longitudinally and circumferentially in the adventitia. Occluded vasa 
vasorum cause localised vessel wall ischaemia, infection and subsequent destruction of 
the medial layer. When arterial wall loses its tensile strength, an aneurysm will develop. 
In the smaller peripheral vessels, septic embolus inoculates the wall through previously 
damaged intima. (Wilson et al 1978, Cornenwett and Johnston 2010.) Atherosclerotic 
inflammation or direct trauma exposes subendothelial cells and stimulates the secretion 
of extracellular-matrix protein as well as the deposition of platelets and fibrin. Several 
bacteria, especially Gram-positive cocci, present with fibrinogen- and fibronectin-binding 
proteins, allowing them to attach to the fibrin deposits. Furthermore, the same proteins 
can induce more platelet activation and aggregation and participate in endothelial cell 
invasion and inflammation. (Tong et al 2015.) The risk group includes current illicit drug 
users and, more rarely, immunocompromised elderly people suffering from Gram-
positive sepsis (Wilson et al 1978). 
Septic embolus can affect virtually any artery, but the aorta as well as the intracranial, 
superior mesenteric and femoral arteries are the predominant targets. Bifurcations and 
congenital coarctations are predisposed sites (Osler 1885, Stengel and Wolferth 1923). 
 
2.3.1.2 Infected aneurysms 
Pre-existing atherosclerotic aneurysms that become infected after haematogenous 
bacterial seeding form a remote infection focus. The inoculation process is somewhat 
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similar to what has been described above. Infected aneurysms are predominantly located 
infrarenally and occur in older population. In a series of over 20 000 autopsies, 
Sommerville found their prevalence to be 3.4% among ruptured aneurysms, 
(Sommerville et al 1959.) Nevertheless, the condition is not the same as asymptomatic 
bacterial presence in aneurysmal thrombus, which is found in approximately 14% of AAA 
cases. The clinical significance of such situation is still unclear, however. (McAuley et al 
1984.) 
 
2.3.1.3 Microbial arteritis 
Microbial arteritis is currently the most common aortic infection, affecting more often men 
and older population. Some level of intimal damage is a prerequisite for a bacterial 
invasion of the arterial wall during bacteraemia, which is why the aorto-iliac and femoral 
arteries or congenital defects are the preferred locations. Microabscesses and 
suppuration cause wall perforation and aneurysm formation appearing saccular or 
multilocular in CT. (Wilson et al 1978, Cornenwett and Johnston 2010.) Typically, patients 
are immunocompromised due to malignancies, malnutrition, diabetes or autoimmune 
disorders. Furthermore, patients on haemodialysis are more prone to an arterial infection 
due to immunosuppression, atherosclerotic arteries and intravascular catheters, and they 
are also more often Staph. aureus carriers (Lee et al 2000, Oederich et al 2001, Hsu et 
al 2005). Concomitant or recent infections as a possible cause of a mycotic aneurysm 
can be identified in 46%–75% of cases and can comprise virtually any infection: 
gastroenteritis, a soft tissue or wound infection, osteomyelitis or septic arthritis, 
pneumonia, urinary tract infection, etc (Mundth et al 1968, Brown et al 1984, Oderich et 
al 2001, Sedivy et al 2012, Sörelius et al 2014). 
 
2.3.1.4 Post-traumatic infected false aneurysms 
Post-traumatic infected false aneurysms are sequelae of repetitive attempts at a venous 
injection, commonly found in the groin area. Usually, a pseudoaneurysm forms due to an 
arterial puncture, and infection develops later. Patients are young and predominantly 
intravenous illicit drug users. Common sites of such pseudoaneurysms are femoral, 
carotid and subclavian arteries. (Qiu et al 2016, Wilson et al 1978.) 
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2.3.1.5 HIV-related aneurysms 
HIV-related aneurysms afflict young population, appear in advanced stages of disease 
and favour atypical locations: the aorta, carotid, femoral and popliteal vessels. Peri-
arteritic fibroproliferative granulomatous inflammation occludes vasa vasorum with a 
cellular infiltrate, causing adventitial fibrosis. Medial fibrosis, muscle damage and elastic 
fragmentation follows. Internal elastic laminal fragmentation and calcifications occur in 
the intimal layer.  HIV-related aneurysms develop without bacterial seeding; however, 
secondary infections are possible. (Pillay et al 2015.)  
 
Etiology of mycotic aortic aneurysms, as a subject of current thesis, involves the 
subgroup of microbial arteritis, infected and mycotic aneurysms.  
 
????? ?????????????
During the pre-antibiotic era, 95% of arterial infections leading to aneurysms were caused 
by bacterial endocarditis. Streptococci, staphylococci and pneumococci were the most 
commonly cultivated bacteria (Osler 1885, Stengel and Wolferth 1923, Parkhurst and 
Dekcer 1955). After introduction of penicillin, embolic complications caused by valvular 
vegetations dropped from 80% to 45%, and the bacteriology of aortic infections became 
more variable (Wilson et al 1978). In their review of literature, Brown reported, that after 
the year 1965, Staphylococcus aureus (30%) has been the most common bacteria found 
in infected arterial aneurysms, followed by Salmonella (10%) and Streptococcal (10%) 
species. Gram-negative aerobes such as Clostridium, Pseudomonas and E. coli became 
more prevalent, and anaerobes Peptostreptococcus and Bacteroides emerged. Brown 
realised that over-use of broad-spectrum antibiotics would reveal a new spectrum of 
pathogens in the future. (Brown et al 1984.) 
Currently, the spectrum of pathogens causing primary aortic infections has been divided 
in two. In the first, Salmonella is overwhelmingly dominant in Eastern Asia, and the other 
is dominated by Gram-positive bacteria presenting in Europe and Northern America.  
In Western countries, Staphylococcus spp (15%–31%), Streptococcus spp (10%–22%) 
and Salmonella spp (9%–41%) are represented more equally; followed by E. coli (2%–
14%), Pseudomonas aeruginosa (3%–9%), Enterococcus spp (4%) and others (Brown 
et al 1984, Oederich et al 2001, Dubois et al 2010, Vallejo et al 2011, Sedivy et al 2012, 
Sörelius et al 2014, Sörelius et al 2016).  
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In Asia, Salmonella spp (21%–80%) are the main causative agents, with Staphylococcus 
spp (5%–21%), Streptococcus spp (2%–11%), E. coli and Klebsiella (6% each), and 
Mycobacteriae (4%–7%) cultivated less often (Hsu et al 2002, Luo et al 2003, Hsu et al 
2004, Woon et al 2008, Kan et al 2007, Kan et al 2009, Yu et al 2011, Lin and Hsu 2014, 
Luo et al 2017). 
Staphylococcal strains are the most common cause of bacteraemia in Western countries 
(35%) (Fluit et al 1999). The situation is different in Asia, where a systematic review 
revealed a salmonella infection in 38% of 1 784 blood-culture-positive adults, 8% of which 
were caused by Non-typhoidal Salmonellae capable causing vascular infections. (Deen 
et al 2012) The speculation, why Salmonellae spp dominate in Asia, is linked to poor 
hygiene and consumption of goods bought from local markets without sanitation control. 
In combination with immunosuppression and atherosclerotic changes, salmonella 
bacteraemia becomes a strong risk factor for Asian people (Cohen et al 1987). 
Salmonella is a Gram-negative biofilm-forming facultative anaerobic rod, which belongs 
to Enterobacteriaceae family. The species of Salmonella typhi and paratyphi cause 
enteric fever, but bacteria capable of invading the intima during septicaemia and causing 
arterial infections are known as Non-typhoidal salmonellae. The non-typhoid group 
includes several serotypes, which are normally hosted by animals and contamination 
occurs via food products. (Velge et al 2012.) The bacteraemia can appear secondarily 
after gastroenteritis or primarily, and cause focal infections such as osteomyelitis, urinary 
tract infections, soft tissue infections, microbial arteritis and endocarditis. The most 
common serotypes associated with arterial infections are S. typhimurium, S. 
choleraesuis and S. enteritidis. (Wilson et al 1978, Cohen et al 1987.) Non-typhoid 
salmonella has predilection for arterial infections. The exact mechanism of cell invasion 
is poorly understood, but in order to establish a disease, salmonella has several 
mechanisms of entering the phagocytic cells and hijacking them. (Velge et al 2012.) 
Salmonella prefers atherosclerotically damaged aorto-iliac vessels. Once vessel 
suppuration occurs, the aneurysm formation is considerably fast, but obscure. Ruptures 
of salmonella-induced aneurysms occur at smaller diameters, which is why prompt 
treatment is necessary (Mundth et al 1968, Cohen et al 1987, Jarret et al 1975, 
Trairatvorakul et al 1990, Valentine et Chung 2012). 
A substantial amount of bacterial cultures remain negative (7%–42%) (Oderich et al 
2001, Kan et al 2007, Woon et al 2008, Dubois et al 2010, Lin and Hsu 2014, Sörelius et 
al 2014, Sörelius et al 2016, Luo et al 2017). Blood cultures are positive even less often 
– 53% –78% of the cases (Mundth et al 1968, Oderich et al 2001, Woon et al 2008, 
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Sörelius et al 2014, Sedivy et al 2012). Many patients are treated with antimicrobial 
therapy prior culture acquisition, which might contribute to negative cultures, or some 
bacteria are just difficult to cultivate. Furthermore, when MAAs are treated 
endovascularly, tissue-samples for bacterial cultivation cannot be obtained and number 
of culture-positive patients decreases even further (Sörelius et al 2014). Such negative 
results, however, complicate the selection of antimicrobial therapy and demand more 
broad-spectrum medications. 
 
??? ?????????????
????? ???????????
The incidence of mycotic aortic aneurysms is estimated to be 0.65%–1.3 % of treated 
aneurysms in Western countries and 3%–13.3% in East Asia (Reddy et al 1991, Müller 
et al 2001, Oderich et al 2001, Luo et al 2003, Yu et al 2011, Sörelius et al 2014). There 
are no population-based studies on the subject, and the estimates have been calculated 
on a per centre basis in the few studies, since data on patients treated conservatively 
and those who have died prehospitally are often missing. The reported incidence has 
decreased after introduction of antibiotics and surgical treatment, however, the true 
global incidence is probably higher, since data is lacking from African countries, where 
HIV, non-typhoid salmonella, malnutrition and hygiene problems are common (Deen et 
al 2012). 
 
????? ??????????
Before surgical management, all cases were fatal (Sommerville et al 1952). After the first 
successful surgery in 1962, the survival rate improved with development of antimicrobial 
therapy and surgical skills. Currently, the early survival rates of surgically treated patients 
range from 81% to 95% in case of endovascular treatment and from 74% to 79% in case 
of conventional surgery. However, the early survival benefit of EVAR disappears, and 
the estimated survival at 5 years is 50%–60%. The late mortality is linked to recurrent 
infectious complications, since graft reinfections are lethal in 70% of cases. (Oderich et 
al 2001, Sedivy et al 2012, Sörelius et al 2014, Sörelius et al 2016.) Conservative 
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treatment with antimicrobials carries very high mortality rate, and mycotic aortic 
aneurysm with no treatment is eventually fatal (Lin and Hsu 2014).  
 
??? ????????? 
The lack of consensus regarding the definition and diagnosis of mycotic abdominal aortic 
aneurysms makes a critical evaluation of existing data difficult. It is easy to distinguish 
between an AGI, AEF and mycotic abdominal aortic aneurysm (MAAA), but 
differentiating an inflammatory aneurysm from a mycotic one might be challenging, 
especially after EVAR application and unavailability of aortic wall bacterial culture. 
An MAAA is defined as an aortic aneurysm caused by bacterial infection in aortic wall. 
Since bacterial presence is often hard to prove, a common agreement exists to accept 
the diagnosis based on combinations of four criteria. Any suspicion based on clinical 
signs and laboratory findings, must be supported by imaging studies and/or perioperative 
findings (Woon et al 2008, Luo et al 2011, Sörelius et al 2014, Lin and Hsu 2014, Sörelius 
et al 2016, Luo et al 2017, Sörelius et Di Summa 2018). Despite some authors 
highlighting a compulsory positive bacterial culture, it is not considered a prerequisite, 
when antimicrobial therapy has been started prior sample acquisition (Mundth et al 1968, 
Müller et al 2001, Luo et al 2011, Vallejo et al 2011, Sörelius et Di Summa 2018).  
 
????? ??????????????????????
MAAAs are highly symptomatic, presenting with abdominal or back pain and fever in 
46%–100% and 48%–99% of the cases, respectively (Soravia-Dunand et al 1999, 
Oderich et al 2001, Hsu et al 2004, Woon et al 2008, Yu et al 2011, Sedivy et al 2012, 
Lin and Hsu 2014, Sörelius et al 2014, Sörelius et al 2016, Luo et al 2017). Of patients, 
12%–59% arrive at the hospital in shock due to rupture rather than due to sepsis (Mundth 
et al 1968, Soravia-Dunand et al 1999, Müller et al 2001, Oderich et al 2001, Hsu et al 
2004, Sörelius et al 2016). Contained rupture into infectious tissue is common. 
Concomitant infections are often present, and may cause the patients to have confusing 
symptoms: back-pain due to discitis, osteomyelitis, and pyelonephritis; joint pain due to 
arthritis; flu-like symptoms due to pneumonia, etc. A historical symptomatic triad, such 
as abdominal pain, fever and pulsatile abdominal resistance are seen rarely (Mundth et 
al 1968, Wilson et al 1978). 
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????? ????????????????????
Elevated inflammatory markers are one cornerstone of an MAAA diagnosis. White blood 
cell count is elevated in 54%–89% of the cases and CRP rises above normal level in all 
cases (Oderich et al 2001, Hsu et al 2004, Woon et al 2008, Vallejo et al 2011, Sörelius 
et al 2014). Blood cultures are positive in 53%–85% of patients and the probability is 
higher if antimicrobial treatment has not been administered yet. (Soravia-Dunand et al 
1999, Mundth et al 1968, Oderich et al 2001, Woon et al 2007, Sörelius et al 2014, Sedivy 
et al 2012). Continuous or recurrent bacteraemia is typical of arterial infections, especially 
with Salmonella (Soravia-Dunand et al 1999). Nevertheless, continuous bacteraemia 
despite antimicrobial treatment may refer to valvular vegetations or intestinal erosion 
(Cohen et al 1987). To improve the results of bacterial samples, board-spectrum PCR 
should be used to define causative agent by means of DNA sequencing.  
?
????? ??????????????????????
Imaging studies have a crucial role in MAA diagnosis; therefore, fast and easily 
accessible CTA is current gold standard in imaging of aortic infections. It enables the 
evaluation of vascular anatomy and periaortic tissue, identification of infectious 
processes in aorta with associated complications and other intra-abdominal infection 
focuses. The first signs of aortic infections are arterial wall irregularity, peri-aortic soft 
tissue oedema, a soft tissue mass and periaortic gas. As the infection progresses, an 
aneurysm develops. A mycotic aneurysm is eccentric and saccular or multilocular. In 
contrast to atherosclerotic fusiform aneurysms, mycotic ones rarely present with 
calcification and thrombus. A rupture can be detected as an extravasation into the 
surrounding tissues or haematoma adjacent to aorta (Lee et al 2008). Contained 
ruptures, however, are sometimes hard to distinguish from soft tissue mass and are 
therefore not revealed until perioperatively. Rapid aneurysm expansion over a short 
period of time is characteristic of MAAA (Valentine et Chung 2012). Most common 
findings are periaortic soft-tissue mass and saccular aneurysms, present in 30%–50% 
and 52%–95% of the scans, respectively. Periaortic gas is rare, presenting in 10%–16% 
of cases (Hsu et al 2002, Lai et al 2011, Vallejo et al 2011, Sedivy et al 2012, Sörelius et 
al 2014, Sörelius et al 2016).  
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If CTA is contraindicated, current technology in magnetic resonance angiography (MRA) 
can diminish motion artefacts and improve resolution for a very precise evaluation of 
perivascular tissues and aorta (Lee et al 2008). 
Radionuclide scintigraphy techniques are used in equivocal cases, and 18F-FDG-PET/CT 
can be employed during follow-up in selected cases, before the discontinuation of anti-
microbial treatment, for instance (Sedivy et al 2012). 
 
? ???????????????????????????????????????????
The treatment methods have evolved, and the results improved significantly over the 
years. Furthermore, axillobifemoral reconstruction as a gold standard from last century, 
has now become a marginal part of selection of treatment methods, and is only used for 
limited indications (Berger and Moll 2011). 
Abdominal aortic infections encompass mycotic abdominal aortic aneurysms and aortic 
graft infections. Aorto-enteral erosions and fistulas are a subgroup of the latter, with 
different pathophysiology and microbiology, specifications of surgical treatment and an 
inferior outcome. Open surgery, including the resection of infected material, debridement 
and lower limb revascularisation, in combination with antimicrobial therapy is the 
cornerstones of infection eradication. However, during the past 20 years, MAAAs have, 
to an increasing extent, been treated with endovascular devices without the resection of 
the infected aneurysm. Due to the paucity of evidence, the debate continues in order to 
establish the preferred reconstruction material and revascularisation method.  
 
??? ????????????????????????
Resection of the infected graft or mycotic aneurysm with meticulous debridement and in 
situ aortic reconstruction is the most prevalent method in treatment of abdominal aortic 
infections today. Being anatomical, it offers better patency rates and fewer amputations 
than axillobifemoral bypass (AXBF). However, controversy concerning the preferred 
conduit material still exists.  
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????? ??????????????????
Prosthetic interposition is most commonly accomplished using silver-coated or 
rifampicin-soaked grafts to provide additional protection from reinfection (see more 
details in section 1.4 Prevention). Encouraged by the results of comparing AXBF and 
prosthetic reconstruction for AGI, Oderich reported on rifampicin-soaked prosthetic 
reconstructions for 54 AEF patients and found a postoperative mortality of 9%, no 
amputations and a reinfection rate of 4% (Oderich et al 2006 and 2011). Similar results 
were reported after 15 infected EVAR reconstructions, with one fatal reinfection during 
the median follow-up (FU) of 14 months and no other graft complications (Fatima et al 
2013). However, in all these studies, the authors emphasized patient selection and 
excluded patients with gross purulence or a large abscess in operating area. Circular 
omental wrapping to eliminate dead space, keep graft separated from the bowel and to 
enhance perigraft blood circulation was an important part of the method. (Oderich et al 
2011, Fatima et al 2013.)  
 
Figure 3 Illustration of in situ reconstructions with the interposition of a prosthetic graft (A) 
and femoral veins (B). 
In a multicentre study with 197 EVAR explants due to infections, 111 reconstructions 
were performed with in situ prosthetic grafts, 59% of which were rifampicin-soaked. 
A B 
Review of the Literature 
43 
Operation times were significantly shorter compared to reconstructions with 
cryopreserved allografts (CAA) or autologous femoral veins (FV), and albeit graft failures 
occurred in all groups, late mortality was higher among patients with prosthetic as 
opposed to biological reconstructions: 47% vs 29%, respectively. The lowest 5-year 
survival rate was 12% for patients with bare prosthetic grafts. However, 11 extra-
anatomical bypasses were added to prosthetic in-line reconstruction for survival analysis, 
with a possible negative influence on the outcome. (Smeds et al 2016.) 
In series by Batt, 27 consecutive aortic infections were treated with silver-acetate 
prosthetic grafts despite gross purulence in ten cases and MRSA in two. Copious 
irrigation with povidone-iodine solution prior to graft insertion was considered crucial, as 
well as omental wrapping of implanted graft. Perioperative mortality was 14.8%, of which 
3 patients had AEF and one an AGI with upper anastomotic rupture. There was no 
additional mortality during the median FU of 17 months and estimated 2-year survival 
was 85%. One patient presented with a local recurrence of infection (3.7%). (Batt et al 
2003.) Two more small studies showed that silver-grafts are not inferior to cryopreserved 
or fresh allografts regarding mortality or graft-related complications (Bisdas et al 2011, 
Pupka et al 2011).  
Several patient series have been reported in treatment of mycotic aortic aneurysms, 
where in situ prosthetic repair has been preferred reconstruction method until recently in 
supra- and infrarenal mycotic aortic aneurysms (MAA), yielding an early mortality rate of 
5%–18% and reinfection rate of 5–21% (Hsu et al 2002, Lai et al 2011, Lin and Hsu 2014, 
Sörelius et al 2016). The mortality risk was higher with emergency procedures and 
concomitant GI-reconstruction due to advanced disease. After “elective” MAA surgery, 
when patients have been treated with antibiotics for up to 4 weeks preoperatively to 
suppress the inflammation and eliminate bacteraemia, the reinfection rate falls to 4% and 
5-year mortality rate in 2 small series to 5% (Uchida et al 2013, Yu et al 2011). It has 
been speculated that the insertion of a prosthetic (endo)graft would be safe in the case 
of an MAA after 4 weeks of preoperative iv-antibiotic treatment (Lin and Hsu 2014, 
Sörelius et al 2016). 
The advantages of prosthetic reconstructions are availability, shorter operating time, 
excellent patency and almost no amputations, reasonable cost and good early 
postoperative outcome in non-emergency settings. However, considerable rates of 
reinfections and subsequent late mortality are reasons why biological in situ grafts have 
been introduced.  
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????? ?????????????????????????
The fresh allografts implanted in the 1970s were discouraging and complicated with graft 
ruptures, aneurysmatic degenerations and occlusions. In 1988 Kieffer decided to use 
fresh allografts as a bridge to definitive prosthetic grafting until the infection had subsided, 
but outcome was surprisingly good and only few patients underwent late prosthetic 
grafting despite numerous occlusive events and reoperations. In 1996, due to changes 
in legislation, Kieffer et al shifted to using CAAs. In a series of 179 patients, aorto-iliac 
aortic infections were treated with fresh allografts in 111 patients, and with CAAs in 68 
patients. During the postoperative period, all nine patients, suffering graft complications, 
were among fresh graft recipients and four of those patients died due to graft rupture 
(2.2%). During a mean FU of 46-months, one fatal CAA rupture occurred due to 
reinfection and two more fresh grafts ruptured after silent dilatation. Second reinfection 
was reoperated. Forty-seven patients suffered non-infective graft complications, such as 
thrombosis or dilatation with fresh allograft recipients dominating in this group. Despite a 
significant number of reinterventions, the estimated 5-year survival was 55%. Fresh 
allografts appeared as a risk factor for complications and fresh thoracic allografts a 
significant risk factor for aortic graft complications. Nevertheless, late reinfection rate was 
1.4%, and only one patient needed amputation. Late deterioration of fresh allografts was 
speculated to be immunomediated. (Kieffer et al 2004.)  
A variety of results have been reported regarding durability of CAAs. CAA is very infection 
resistant, with reported reinfection-rate of 0% to 4%; however anastomotic ruptures as 
well as late graft occlusions and aneurysmatic dilatations require reinterventions in 5%–
55% of the cases (Lesėche et al 2001, Vogt et al 2002, Bisdas et al 2010, Harlander-
Locke et al 2014, Ben Ahmed et al 2017, Heo et al 2017, Lejay et al 2017). The early 
mortality of 6%–28%, nor the 5-year mortality of 36%–60%, have no significant 
advantage compared to other in situ reconstructions (Bisdas et al 2010, Harlander-Locke 
et al 2014, Touma et al 2014, Ben Ahmed et al 2017, Lejay et al 2017). Despite graft 
occlusion, the reported limb salvage is 100% (Lesėche et al 2001, Vogt et al 2002, 
Harlander-Locke et al 2014, Lejay et al 2017). 
A multicentre study from the United States including 220 patients reported 14% of graft-
related complications and 5% rate of graft explantations. Predicting factors for graft 
complications were age >70 years, peripheral vascular disease and virulent, gram-
negative organisms. Graft explant was associated with age and partial prosthetic graft 
reconstruction. Freedom from graft complications was estimated to be 80% at 5 years. 
(Harlander-Locke et al 2014.) Despite other postoperative complications, the recurrence 
Review of the Literature 
45 
of graft infections is low. During the early postoperative period, it is hard to distinguish 
whether graft ruptures are due to friability or reinfection, and the reinfection rates of 0%–
4% may therefore be underestimated. Despite continuous controversy, no evidence 
exists of a relationship between the blood type (ABO) mismatch of CAAs and graft-
related complications (Della Schiava et al 2016, Minga Lowampa et al 2016, Heo et al 
2017). 
In a multicentre review with 33 infected EVAR explants, 23 patients were treated with in-
line CAA reconstruction and 10 patients with AXBF, in situ rifampicin-soaked silver 
prothesis or autologous femoral veins. No differences in graft performances were seen. 
Nevertheless, two CAAs ruptured during the early period due to a reinfection in AEF 
patients. (Chaufour et al 2017.) 
Technical details could diminish the graft-related complications after CAA reconstruction: 
following proper thawing protocol, using the appropriate size and length of graft, tension-
free anastomosis with spatulation in case on size mismatch, securing side branches with 
polypropylene sutures through the CAA wall, circumferential reinforcement to the 
anastomoses, application of gentamycin-impregnated fibrin glue around the 
anastomoses and aggressive drainage of intra-abdominal collections and wounds. 
Omental wrap and sartorius myoplasty in the groin are recommended. By implementing 
these measures, Vogt et al were able to decrease graft-related complications from 7/10 
to 2/39 patients (80% vs 2.6%) (Vogt et al 2002). 
Downsides of CAA are availability, cost and uncertain durability. Few centres with their 
own tissue banks and organ-harvesting programmes have continuous access, although 
most centres are able to obtain a CAA within a few days, excluding emergency use 
(Bisdas et al 2011, Lejay et al 2017). 
 
????? ?????????????????????????
After Nevelsteen and Clagett reported the first series of autologous venous aortic 
reconstructions with early mortality of 10% and no reinfections, the use of femoral vein 
as an aortic conduit has widely spread. In Calgett’s series, a neoaorta was reconstructed 
in half of the patients using saphenous veins, and 64% of these occluded within the first 
year, whereas no graft complications occurred among large-calibre FV conduits. (Clagett 
et al 1993, Nevelsteen et al 1995.) 
Femoral veins with no post-thrombotic changes and a minimum diameter of 6–7 mm, can 
be harvested from the popliteal fossa to confluence with profunda vein and used as an 
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autologous conduit in aortic infectious reconstructions (Clagett et al 1993). The distal 
popliteal vein must be spared, and care must be taken to not leave a proximal “stump” to 
allow thrombus formation (Neufang and Savvidis 2016). Valves should be excised after 
vein eversion under direct visual control, since valve remnants cause stenotic 
complications (Beck et al 2008). A new aorta can be reconstructed in several 
configurations, however, a “pantaloon” shape is most commonly used after proximal 
ends are cut open for few centimetres and sewn together with continuous suture 
(Figure3). FVs are kink-resistant when compared to saphenous vein grafts (Clagett et al 
1993, Smith and Clagett 2008, Beck et al 2008, Neufang and Savvidis 2016). 
A review of 187 FV reconstructions showed postoperative mortality of 10%, procedure-
related mortality of 14% and reinfection rate of 5%. Six out of ten reinfection-patients 
were treated for an AEF, five 5 of whom had new duodenal leakage. A few patients had 
no obvious signs of infection, but since they were immunocompromised and initially 
suffered from a polymicrobial infection, the infection was considered to be the most likely 
agent. Factors for poor early outcome were a Candida infection, Klebsiella, Bacteroides 
fragilis, sepsis and blood loss of >3 litres; poor late outcome was associated with age of 
>64 years, initial graft rupture, chronic kidney disease (CKD) or a fungal infection. Overall 
survival at 5 years was 52%, but in cohorts with and without AEF 18.4 % and 56.7%, 
respectively. FVs seem infection-resistant, but in the circumstances of impaired host 
defences and continuous bacterial presence, risk of reinfection remains. (Ali et al 2009.) 
Factors possibly predisposing to graft reinfections include malnutrition, 
immunocompromised state, active cancer, duodenal leak/continuous bacterial presence 
and a polymicrobial, especially fungal infection. Severely debilitated patients, therefore, 
may benefit form extra-anatomical reconstructions. (Ali et al 2005.)  
The 5-year survival rates are similar to those of other in situ reconstructions at 45–70%, 
but late stenotic graft complications appear. The early amputation rate is 2–7% and limb 
salvage at 5 years 89%–96%. The primary patency rates at 5-years are 75%–91%. 
(Daenens et al 2003, Ehsan and Gibbons 2009, Beck et al 2008, Dorweiler et al 2013.) 
Beck reported 11 (4.6%) stenotic lesions and 9 (3.8%) occlusions among 240 aortic 
reconstructions and found small vein size (<7.2mm), extensive smoking and 
cardiovascular disease as risk factors (Beck et al 2008).   
Vein harvesting is generally well-tolerated when distal popliteal vein is left intact and 
drainage to common femoral vein unobstructed. Mild swelling occurs in 15% of the 
patients; severe swelling with skin changes and ulcers are extremely rare. Postoperative 
fasciotomy is necessary in 12% of the cases and usually associated with previous severe 
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limb ischaemia, preoperative volume overload, a too distal deep vein or concomitant 
ipsilateral saphenous vein harvest. (Smith  and Clagett 2008, Neufang and Savvidis 
2016.) 
Main downsides of FV applications are extensive surgical trauma for a frail patient and 
long duration of operation of up to 10–12 hours (Nevelsteen et al 1995, Ali et al 2009). 
However, in case of a non-emergency situation, FVs may be mobilised a day prior to 
aortic reconstruction without compromising the outcome (Ali et al 2008). 
 
????? ?????????????????????????????
Xenopericardial grafts are currently self-made from a bovine, porcine or equine 
pericardium and sewn together into a tube configuration. Additional smaller-diameter 
tubes can be added as aortic graft limbs. Advantages are constant availability, ease of 
handling, inexpensiveness and biocompatibility. Few small series with up to 35 patients 
have been published with early mortality of 7.7%–31% and mid-term total mortality of 
32%–49% (Czerny et al 2011, Kubota et al 2015, Lutz et al 2016, Weiss et al 2017). 
Among a total of 71 patients, one early anastomotic rupture was encountered and three 
anastomotic pseudoaneurysm were operated on, two of which were considered 
occurring due to technical problems rather than graft complications. Three studies 
reported no reinfections, whereas Lutz reported two reinfection-ruptures, one of which 
was tube graft rupture and the other was rupture of a native artery adjacent to 
anastomosis. (Czerny et al 2011, Kubota et al 2015, Lutz et al 2016, Weiss et al 2017.) 
Xenopericardial tube grafts (XPT) seem infection-resistant, and no late degenerations 
have been reported, however, the evidence is scarce and data on durability is lacking.  
 
Two meta-analyses have compared in situ and extra-anatomical reconstructions 
including all of the above-mentioned reconstruction materials except XPTs. Both studies 
concluded that in situ reconstructions are superior regarding mortality, reinfections, 
conduit failures and amputations. Rifampicin-soaked and silver-prostheses are 
associated with lowest amputation rates but carry the highest risk of reinfection (11%). 
Bare polyester grafts remain inferior to silver or rifampicin grafts. FVs are the most 
resistant to reinfections, followed by cryopreserved grafts, but amputation-rate is high 
(2%–24%) despite a low rate of graft occlusions (2%). Early mortality was significantly 
lower for FVs (10%) and rifampicin-soaked prostheses (12%) compared to CAAs (22%) 
and silver-prostheses. Late survival was better for patients treated with biological grafts. 
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Batt et al concluded that, for older individuals, silver prostheses would be preferable, 
while FVs should be preferred for younger patients without an AEF and silver- or 
rifampicin-soaked prostheses for patients with an AEF.  (O’Connor et al 2006, Batt et al 
2018.) 
??? ????????????????????
   
 
of 81%, but only 50% survived one year. Half of the deaths in the cohort were infection-
related. (Sedivy et al 2012.) A multicentre study of 124 patients confirmed the 
perioperative advantage of endovascular treatment, with an early survival of 91%. 
Nonetheless, 27% of survivors developed infection-related complications that were fatal 
in 70% of cases. The total infection-related mortality was 19%, and the survival 
advantage disappeared: the one- and 5-year survival rates were 76% and 55%, 
respectively. (Sörelius et al 2014.) A Swedish nationwide study once again showed the 
advantage of EVAR over open repair during the first 30-days, with respective survival 
During the last few decades, EVAR has 
been adopted as the preferred treatment 
in case of mycotic aortic aneurysms in 
several centres. A systematic review by 
Kan reported postoperative survival of 
89.6 % and 2-year survival of 82.2%. 
They divided patients into healed patients 
and those with persistent infection after 
operation and reported 1-year survival 
rates of 94% vs 39%, respectively. 
Predictive factors for persistent infection 
were older age, ruptured aneurysm or 
fistula and perioperative fever. 
Preoperative antibiotic treatment lasting 
>1 week and adjunctive procedures, such 
as collection drainage or surgical 
debridement were protective. (Kan et al 
2007.) A study from Czech Republic 
presented  postoperative survival  rate  of  
Figure 1 Illustration of endovascular 
treatment for mycotic abdominal 
aortic aneurysm 
Review of the Literature 
49 
rates of 99% and 89%, but difference vanished at 5-years (58% and 60%, respectively). 
However, since the open repair overwhelmingly constituted prosthetic reconstruction, the 
respective reinfection rates of 18% and 24% were similar in both groups. Patients treated 
with open surgery were 7 times more likely to expire during the first 3 months. (Sörelius 
et al 2016.) Nonetheless, the authors who approve of EVAR emphasize the duration of 
preoperative antimicrobial treatment of up to 4–6 weeks when possible to decrease the 
bacterial load. Postoperatively, lifelong suppression is often necessary. (Kan et al 2007, 
Kan et al 2010, Sörelius et al 2014.) EVAR is feasible and provides excellent early 
survival, but since reinfection risk is substantial, patients with aforementioned risk factors 
and non-salmonella infections should be closely followed, and the threshold for a 
conversion should be low (Sörelius et al 2014). 
In contrast to native infections, in case of AGI, EVAR is indicated only for rupture or AEF 
with haemodynamic instability. In a meta-analysis of mixed case-reports of primary and 
secondary AEFs, postoperative mortality was 8.5% and recurrent bleeding appeared in 
36% and sepsis in 41% of cases. Estimated 2-year survival was 52%. Patients at risk 
presented with large fistulas, had tube graft placement, were septic, did not have 
intestinal repair and developed new AEFs. Patients with no additional intestinal repairs 
were at high risk of infectious complications (48% vs 0%). (Kakkos et al 2011.) For 
patients with life expectancy of less than 6 months, EVAR and lifelong antibiotic treatment 
could be considered a definitive repair, for patients with longer life expectancy, EVAR 
can serve as a bridge only (Haidar et al 2017).  
Treating EVAR infection with re-lining or device extension is unsuccessful with or without 
additional drainage (Lyons et al 2013).  
 
??? ???????????????????????????????
Resection of infected material and debridement, followed by extra-anatomical 
axillobifemoral bypass, is an old technique with the main advantage of inserting a new 
reconstruction through uninfected planes (Figure 2). When extra-anatomic reconstruction 
is performed first, aortic cross-clamping and the subsequent resection of the infected 
graft and tissue will have a lesser effect on the cardiac afterload. Therefore, procedure 
is better tolerated for patients in poor condition and of an advanced age. (Dubois et al 
2010.) The shortcomings of axillobifemoral bypass (AXBF) are a high rate of reinfections, 
occlusions and aortic stump blowout. Furthermore, the rate of stump blowout increases 
to 31% and rate of reinfections to 75%, when AXBF is reconstructed due to an AEF 
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(Jauseeran et al 1997, O’Connor et al 2006, Woon et al 2008, Batt et al 2011). Albeit 
new prosthesis is inserted into non-infected area, continuous bacteraemia, possible 
perioperative contamination, immunocompromised condition and poorer perfusion in 
subcutaneous fat plane make the new graft more susceptible to reinfection. In 
conclusion, AXBF reconstruction carries a higher long-term mortality of 26%–60% 
compared to in situ operations with a corresponding rate of 24%–48% (Berger and Moll 
2011, Charlton-Ouw et al 2014).  
In the light of current evidence, AXBF remains rather a bail-out option in case of gross 
purulence in the abdominal cavity, active osteomyelitis, discitis, psoas abscess, and 
multiresistant virulent bacteria for patients in extremely poor condition or of an advanced 
age (Soravia-Dunand et al 1999, O’Connor et al 2006, Wilson et al 2016, Batt et al 2018).  
 
 
Figure 4 Illustration of a mycotic abdominal aortic aneurysm (A) and axillobifemoral bypass 
(B) after aneurysm resection.  
?
??? ???????????????????????????????????????????????
Indications for partial aortic graft resection are prohibitive risk for total explant and, 
occasionally, localised or asymptomatic infection. Total retention due to localised 
infection of an extracavitary part is accepted in low-risk patients, when graft is patent and 
A B 
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intact, and patient is not septic. Partial resection can be considered in case of localised 
purulence of the groin, distal anastomosis pseudoaneurysm or limb thrombosis with rest 
of the graft firmly incorporated. Infected and thrombosed graft limbs must be resected, 
since an intraprosthetically organised thrombus is impossible to sterilise. In a prohibitive-
risk patient with septic infection, fluid collections must be drained percutaneously or via 
laparotomy and frequently irrigated with an antibiotic-solution or providone-iodine until 
discharge is clear. Intestinal fistulas have to be repaired. Debridement of perigraft tissue 
is recommended, and exposed parts of graft must be covered with vascularised 
myoplasty or omentoplasty intra-abdominally. Antimicrobial treatment and close 
surveillance are a mandatory part of the treatment. (Szilagy et al 1972, Calligaro and 
Veith 1997 and 2003, Lawrence 2011.)  
Graft preservation carries a lower risk with low-virulent bacteria; however, Calligaro 
reported the long-term results of nine patients with one early death and only one 
reinfection among patients with highly virulent bacteria (Pseudomonas, E.coli, MRSA), 
while using aggressive drainage and debridement (Calligaro et al 2003). In another 
cohort of 17 patients unfit for graft explant, septic relapses occurred in 59% of patients 
during median FU of 57 months, and 59% eventually died due to infection-related 
reasons (Maze et al 2013). Postoperative antibiotics were administered in both series, 
but permanent suppression used only in the latter series. Despite the suppression 
therapy, relapses were frequent and more resistant bacteria occurred. (Calligaro et al 
2003, Maze et al 2013.)  
Endograft retention in case of a symptomatic AGI and solely conservative treatment of 
an MAAA are rather palliative methods only. Based on a recent review, the midterm 
survival after conservative therapy with or without drainage was 67% (Soravia-Dunand 
et al 1999, Lyons et al 2013, Chaufour et al 2017, Li et al 2018). However, small 
unruptured aneurysms can rarely resolved, and Lin reported a mid-term survival of 33% 
among 24 patients (Lin and Hsu 2014). 
   
??? ???? ?????????????????
Antimicrobial therapy is crucial part of management of abdominal aortic infections. 
Antibiotics without a surgical intervention carry high mortality, therefore combination-
therapy is recommended. The treatment should be organised by infectious disease 
specialist and guided by bacterial susceptibility or started with broad-spectrum antibiotics 
and de-escalated based on antibiogram. In case of septic patients, treatment starts 
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immediately after acquisition of two different sets of blood cultures. In non-septic patients, 
additional needle aspiration samples from fluid collections or abscesses are taken under 
ultrasound or CT guidance prior the administration of antibiotics. (Revert et al 2015.) 
Antimicrobial therapy is initiated intravenously with bactericidal medication and 
recommended to be continue for at least 6 weeks postoperatively. When using 
compounds with good bioavailability (rifampicin, fluoroquinolones), conversion to oral 
antibiotics can occur sooner, whereas elevated biomarkers of inflammation are 
normalised. After parenteral treatment, oral medication lasting for 3–6 months may be 
considered, depending on micro-organism isolated, treatment method used and clinical 
course of disease. (Revert et al 2015, Wilson et al 2016.) When biological grafts are 
used, patients are generally treated with antimicrobial medicine for 6 weeks and 
thereafter medication is tailored individually. Life-long suppression, however, is rare with 
biological reconstructions, and used in case of partial graft excision only. (Daenans et al 
2003, Bisdas et al 2010, Dorweiler et al 2013, Weiss et al 2017.) With prosthetic 
reconstructions, life-long suppression is commonly used (Oderich et al 2011, Fatima et 
al 2013, Smeds et al 2016). Relapses may appear after compliance problems; 
furthermore, adverse drug effects and acquisition of resistant organisms are downsides 
of long-term medication (Hsu et al 2009, Oderich et al 2011, Sörelius et al 2016).  
In case of endovascular treatment of MAAA, some authors recommend preoperative 
antibiotic treatment for 4–6 weeks until blood cultures become negative. Thereafter the 
risk for stent graft reinfection is low. (Hsu et al 2002, Kan et al 2007.)  Nevertheless, the 
evidence is lacking and since MAAA carries a high risk of rupture, the delay might be 
fatal.  
Anti-fungal treatment cannot be disregarded in patients with aortic infections. Due to long 
antibiotic treatment, the yeast overgrowth is common, or Candida can be part of the 
intestinal microflora of AEF patients. When a fungus is cultured, 10-days parenteral 
treatment is recommended, and if the cultures remain negative thereafter, oral 
suppression lasting from 6 weeks to 3 months is recommended, if oral medication is 
available. (Revert et al 2015.) 
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Acute renal failure is a definition commonly used describing a rapid decline in glomerular 
filtration rate (GFR) which might require renal replacement therapy (RRT) with or without 
pre-existing renal disease.  However, since even minor changes in renal function are 
linked to increased risk of mortality, the definition should be broader and amenable to the 
prevention, early detection and prompt treatment of renal dysfunction. Therefore, the 
term of acute kidney injury (AKI) was introduced to describe rapid decline of GFR and 
accumulation of uraemic waste products within one week of triggering event, such as 
surgery. (Van Biese et al 2006, Kellum et al 2013.)   
AKI is defined as any of the following: 
? increase in serum creatinine (SCr) by ?26.5?mol/l (?0.3mg/dl) within 48 
hours; 
                  OR 
? increase in SCr to 1.5 times baseline value, which is known or presumed to 
have occurred within previous 7 days 
                  OR 
? urine volume of <0.5ml/kg/h for 6 hours 
(Kellum et al 2013, KDIGO Clinical Practice Guideline for Acute Kidney Injury 2012.) 
 
????? ?????????????
There are a few different classifications, or staging systems, used in current literature for 
AKI. In the earlier literature, an elevation of the preoperative SCr to >176?mol/l (>2mg/dl) 
and the need for RRT were the only two criteria for postoperative renal dysfunction, but 
results are currently reported based on the RIFLE classification (Table 3) or KDIGO 
stages (Table 4), making reporting the results more homogenous and comparable. 
(Chong et al 2009.)  
RIFLE – an acronyme for Risk of renal dysfunction; Injury and Failure of the kidney, Loss 
of kidney function and End-stage renal disease – constitutes a classification of AKI based 
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on international consensus criteria (Bellomo et al 2004). Since urine output and estimated 
GFR are more sensitive, albeit, not very specific, and since SCr is specific, but 
sometimes lags behind in renal injury and recovery, all three parameters were included 
in the RIFLE criteria. Based on aforementioned parameters, RIFLE defines three stages 
of severity of renal dysfunction during the early postoperative period (Risk, Injury and 
Failure) and two outcome measures after 30-day period (Loss, ESRD). (Bellomo et al 
2004, Van Biese et al 2006.) 
After implementing the RIFLE criteria, a group of nephrologists and intensivists, the Acute 
Kidney Injury Network (AKIN), suggested modifications to make the classification more 
 
Table 2. The RIFLE criteria and classification of AKI for adults by Bellomo et al 2004. 
GFR, glomerular filtration rate; SCr, serum creatinine 
 
?
 
Stages 
 
GFR criteria 
Urine 
Output Criteria 
Risk Increase of SCr x1.5  
OR 
GFR decrease >25% 
 
<0.5ml/kg/h for 6 h 
Injury Increase of SCr x 2 
OR 
GFR decrease >50% 
 
<0.5ml/kg/h for 12 
h 
Failure Increase SCr x 3 
OR 
GFR decrease 75% 
OR 
SCr ?350 ?mol/l (?4mg/dl) with acute increase at least 
44?mol/l (0.5mg/dl) 
<0.3ml/kg/h for 24 
h 
(Oligouria) 
OR 
Anuria for 12 h 
Loss Complete loss of kidney function >4 weeks = Persistent acute renal 
failure 
ESRD End-stage Renal Disease (>3 months) 
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sensitive. After two measurements over 48h, an elevation in SCr levels (? 26,5?mol/l or 
0.3mg/dl) was added to the first (Risk) stage, since it is linked to increased mortality 
independently of comorbidities. AKIN also classified patients needing RRT into stage 3 
(Failure) and excluded both outcome criteria. (Metha et al 2007, Kellum et al 2013.) 
Therefore, modified RIFLE classification became quite similar to the latest KDIGO 
staging system. 
Kidney Diseases: Improving Global Outcomes (KDIGO) consensus published guidelines 
for diagnosing and treating AKI in 2012 and defined severity of AKI in three stages. The 
parameters are SCr and urine output, and the lowest criterion defines the stage. New-
onset RRT qualifies for stage three.  (KDIGO Clinical Practice Guideline for Acute Kidney 
Injury 2012.)  
Table 3. Staging of AKI by KDIGO. 
?
??? ???????????????????????????????????????????????
AKI can be classified as pre-renal, acute post-renal obstruction or intrinsic renal disease. 
Pre- and post-renal AKI are the results of extra-renal conditions, which can develop into 
 
Stages 
 
Serum Creatinine 
Urine 
Output 
1 1.5–1.9 times the baseline value 
OR 
?26.5?mol/l (?0.3mg/dl) increase  
 
<0.5ml/kg/h for 6–
12 h 
2 2–2.9 times the baseline value <0.5ml/kg/h for ?12 
h 
   
3 3 times the baseline value 
OR 
Increase in serum creatinine to ?353.6?mol/l 
(?4.0mg/dl)   
OR 
Initiation of renal replacement therapy 
<0.3ml/kg/h for ?24 
h 
OR 
Anuria for ?12 h 
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intrinsic disease without treatment. Ischaemic complications due to renal or suprarenal 
artery clamping in complex aortic surgery are the cause of intrinsic AKI. (Markis and 
Spanou 2016.) 
Aortic cross-clamping at the thoracic level decreases the renal blood flow by 85%–94%, 
leading to a diminished GFR and urine output (Zammert and Gelman 2016). Suprarenal 
clamping and de-clamping induce an ischaemia–reperfusion insult leading to acute 
tubular necrosis that may manifest as AKI. Prolonged warm ischaemia causes tubular 
cell injury and apoptosis. An inability to convert from oxidative to glycolytic metabolism 
makes the epithelial cells of pars recta, and thick ascending tubules of nephron in outer 
medulla, most susceptible to oxygen deprivation. Ischaemia-injured microvessels 
vasoconstrict and, in combination with endothelial-leukocyte interactions and activated 
coagulation cascade, lead to small vessel occlusion. Local oedema due to ischaemia 
and inflammation lead to tubular necrosis. Desquamated injured and apoptotic cells form 
casts, causing tubular obstruction and increased intratubular pressure. Furthermore, now 
uncovered basement membrane is a weak barrier, allowing glomerular filtrates to 
backleak to the interstitium. However, after reperfusion the kidney can recover from the 
ischaemic insult. Replacement of lost tubular cells depends on the migration and 
differentiation of surviving cells; therefore, the repair is often incomplete, and fibrosis 
occurs. Post-ischaemic development of chronic kidney disease is associated with many 
factors, but especially with the chronic activation of macrophages and long-term hypoxia. 
Albeit perfusion is re-established, the amount of microvessels remains decreased, 
causing chronic hypoxia, which leads to chronic kidney injury. (Bonventre et Yang 2011, 
Makris and Spanou 2016.) 
Healthy kidneys should tolerate warm ischaemia for up to 25 minutes, thereafter 
additional protection could be achieved with renal cooling, to diminish the oxygen 
consumption, or with isothermic perfusion (Köksoy et al 2002, Yeung et al 2008, 
O’Donnell et al 2018). 
????? ????????????????????????????????????????????????????
Incidence of AKI is lower after infrarenal aortic surgery, ranging from 2.9% to 15% among 
patients treated with EVAR and from 9.5% to 23% among patients treated with open 
surgery (Chong et al 2009, Castagno et al 2016, Zarkowsky et al 2016, Dariane et al 
2017, Statius van Eps et al 2017). Incidence increases with suprarenal clamping and 
additional renal reconstructions, ranging from 17% to 36% and an incidence of 28% has 
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been reported after complex endovascular procedures encompassing the renal arteries 
(Chong et al 2009, Marrocco-Trischitta et al 2009, Sailer et al 2016, Sugimoto et al 2017, 
O’Donnell et al 2018). 
Postoperative mortality, late mortality and future CKD are associated with increasing 
severity of AKI. Among patients with suprarenal clamp, O’Donnell et al reported higher 
postoperative mortality after kidney injury independently of the preoperative renal 
function – 3.1% without renal dysfunction, 6.2% with AKI and 18.3% for patients on RRT. 
Furthermore, the long-term mortality was also associated with AKI and RRT (O’Donnell 
2018). Similarly, compared to non-AKI patients, occurrence of AKI predicted higher early 
mortality after infrarenal aortic repair with rates of 0.6% vs 4.8%; and in a cohort of mixed-
level aortic clamping – 4.3% vs 35% (Grant et al 2012, Castagno et al 2016). 
Chronic renal disease developed in 15.9% of patients in Sugimoto cohort after supra- or 
inter-renal aortic clamping, 52.9% of those patients suffered AKI previously (Sugimoto et 
al 2017). Sailer reported that postoperative AKI-group was at a 3.01-fold risk of 
developing CKD compared to the non-AKI group (Sailer et al 2016). 
The 5-year survival of patients without postoperative AKI has been estimated to be 77% 
as opposed to the 54% for patients with AKI, while only 23% of the patients on RRT 
survive for three years (Zarkovsky et al 2016). 
 
????? ?????????????????????
The strongest risk factor for postoperative AKI is preoperative renal dysfunction, and it is 
linearly associated with the severity of disease. Other included risk factors are age > 75 
years, preoperative respiratory disease, smoking, hypertension, a symptomatic 
aneurysm and a suprarenal aortic clamp. (Chong et al 2009, Marrocco-Trischitta et al 
2009, Grant et al 2012, Castagno et al 2016, Dariane et al 2017.) In complex aortic 
surgery encompassing renal arteries, the risk of postoperative AKI increases with 
suprarenal aortic clamping time over 25 minutes, suprarenal or supravisceral clamp 
position, additional renal artery reconstruction, male sex, diabetes, and with morbid 
obesity. (Wahlberg et al 2002, Marrocco-Trischitta et al 2009, Chong et al 2009, 
Sugimoto et al 2017, O’Donnell et al 2018.)  
Perioperative hypovolemia, renal artery embolization, low systemic vascular resistance 
due to anaesthetics and renal vein divison may additionally contribute to the development 
of AKI (Marrocco-Trischitta et al 2009, Maxwell and Bell 2017). 
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??? ??????????????????
The early recognition and prevention of further renal damage is the most effective 
treatment of AKI. Further deterioration can be addressed with haemodynamic stability 
and adequate renal blood flow. The first step is to treat the underlying cause if possible. 
Once AKI has developed, the treatment becomes supportive to allow renal recovery. 
Fluid management in combination with vasopressors should be aimed based on 
haemodynamic goals to correct hypovolemia while synchronically avoiding fluid 
overload. Isotonic crystalloids should be preferred if blood products are not indicated and 
colloids avoided. In case of volume overload, loop-diuretics can be used, which may 
stimulate urine output and shift the fluid balance. Nephrotoxic agents should be avoided, 
and alternatives used. (Kellum et al 2012, Ad-hoc working group of ERBP 2012, Bell et 
al 2016, Vaara and Bellomo 2017.)  
Electrolyte abnormalities and acidosis are common complications of AKI. The goal of 
treatment in hyperkalaemia is hiding extracellular potassium in the intracellular space 
and stabilising the cellular membrane. Insulin and glycose infusion forces potassium 
intracellularly, and calcium gluconate stabilizes the membrane. Sodium bicarbonate 
shifts potassium back into intracellular space, but only a limited amount of sodium 
carbonate should be used and only in case of acidosis due to possible cause of 
hypernatremia and subsequent development of fluid overload. Diminished GFR causes 
hypocalcaemia and replacement is recommended, often in combination with the 
treatment of underlying hyperphosphatemia. (Maxwell and Bell 2017.) 
The most effective treatment of electrolyte abnormalities, acidosis, fluid overload and 
azotaemia is RRT. Timing of the initiation of RRT is, however, controversial due to lack 
of evidence. RRT is associated with the risk of complications and, therefore, waiting for 
renal recovery is common. It is widely accepted that combination of severe hyperkalemia, 
severe acidosis, pulmonary oedema and severe uraemia is indication for dialysis, but in 
a less dramatic situation, SCr and urea are often followed. In case of postoperative AKI, 
fluid overload should be considered an indication for RRT and dialysis seen as renal 
support rather than renal replacement. (Kellum et al 2012, Maxwell and Bell 2017.) 
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??? ??????????? ????????????????????????????
????? ??????????????????????
Based on a substantial body of evidence, suprarenal clamping with cessation of renal 
arterial perfusion is a risk factor for postoperative AKI in complex aortic surgery 
(Marrocco-Trischitta et al 2009, Jeyabalan et al 2011, Hobson et al 2018, O’Donnell et 
al 2017). A renal ischaemia time of <25 min has been regarded as considerably safe 
without additional renal protection, thereafter, the risk of AKI increases in conjunction 
with clamping time (Wahlberg et al 2002, Dubois et al 2013, O’Donnell et al 2018, Hobson 
et al 2018). When concomitant renal artery reconstruction is performed, the risk of renal 
injury is elevated even further (Chong et al 2009, Dubois et al 2013). Inter-renal clamping 
does not seem to affect renal function more than infrarenal clamping (Marrocco-Trischitta 
et al 2009). Suprarenal and supramesenteric clamps have been associated with a 
possible visceral embolisation of atherosclerotic debris and are therefore recommended 
to be avoided when possible. Nevertheless, if preoperative imaging excludes 
atherosclerosis or perivisceral thrombus, lowermost clamp is recommended. (Marrocco-
Trischitta et al 2009, Jongkind et al 2010, Kasahara et al 2013, Hobson et al 2018.) 
Supravisceral aorta is most often healthy, but downsides of clamping it are increased 
cardiac afterload and a global visceral ischaemia-reperfusion insult that may additionally 
contribute to postoperative organ dysfunction and AKI (Sarac et al 2002, Hanssen et al 
2008, Marrocco-Trischitta et al 2009, Jongkind et al 2010, Kasahara et al 2013, Yeung 
et al 2016).  
 
????? ???????????????????????????
Pharmacological protection, cold-fluid renal perfusion and temporary shunts are used to 
diminish the effect of an ischaemia–reperfusion injury to the kidneys. Mannitol is an 
osmotic diuretic causing renal vasodilatation and increasing tubular urine flow. As a free-
radical scavenger, it reduces the ischaemia–reperfusion injury. It is widely used before 
suprarenal clamp placement, but albeit several studies have reported mannitol use to 
enhance postoperative urine output, convincing evidence of its benefits in avoid AKI is 
lacking. (Hersey and Poullis 2008, Kellum et al 2012.) Fenoldopam mesylate is a short-
acting dopamine receptor agonist that causes renal vasodilatation and inhibits tubular 
sodium reabsorption. Continuous infusion perioperatively and during early postoperative 
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period has been shown to be renoprotective by one randomized controlled trial in the 
context of cardiac surgery, however data in the specific context of aortic surgery is non-
existent. (Cogliati et al 2007, Kellum et al 2012.) 
 
????? ?????????????????????
Hypothermia reduces cell metabolism and oxygen consumption, there by cooling the 
renal parenchyma to 10 degrees, oxygen consumption decreases to < 5%. After 
suprarenal clamping and opening of the aneurysm sac, small Pruitt catheters are placed 
into renal arteries and, after the initial bolus, continuous perfusion is started. Either, 
Ringer’s solution or saline can be used as a perfusate. Selective use of four-degree 
perfusion is common, when longer renal ischaemia is expected, or if the patient has 
preoperative renal dysfunction. (Yeung et al 2016.) A review by Jongkind comparing 
studies with selective cooling, to studies, where it was not reported, and showed fewer 
cases of new-onset dialysis among patients with cooling: 2.7% vs 5.7%, respectively 
(Jongkind et al 2010). Yeung found no postoperative AKIs after elective repair of a 
juxtarenal aneurysm with renal cooling. Study among patients with ruptured a juxtarenal 
aneurysm reported postoperative mortality of 48%, where 2 out of 10 patients who died 
received cold perfusion and 8 had not. Out of 11 patients suffering a postoperative AKI, 
10 were operated on without cold perfusion. (Yeung et al 2008 and 2010.) The benefit of 
cold perfusion was also indicated in a recent register-based study including 2 635 
patients with suprarenal aortic clamping, where renal cooling was associated with a lower 
risk of AKI, after renal ischaemia time exceeded 25 min (O’Donnell et al 2018).  
?
????? ???????????????????
To overcome the risk from longer suprarenal clamping time, several temporary perfusion 
methods are available. Commonly used methods in thoracoabdominal aortic surgery 
encompassing visceral segment of aorta, are left heart bypass or cardiopulmonal bypass 
with selective organ perfusion (Aftab and Coselli 2014, Waked and Schepens 2018). 
However, selective renal perfusion via cannulation does not appear superior to cold 
perfusion in thoracoabdomnal aortic surgery (Köksoy et al 2002). Temporary arterial 
shunts, such as axillo-femoral bypass, are more commonly used in case of kidney 
transplants to maintain physiologic pulsatile perfusion. Several small series and case 
reports are published introducing different temporary shunts to minimise renal ischaemia 
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time and to maintain physiologic perfusion as the safest option. Sidhu reported on 15 
aorto-iliac reconstructions where temporary bypass was used in 10 patients, cold renal 
perfusion in two and no protection in three cases. The only transplant loss occurred in 
the no-protection group with subsequent mortality, and only one patient suffered 
temporary renal transplant dysfunction in bypass group. (Sidhu et al 2003.) Monnot found 
no allograft dysfunction in a series of three patients and preferred this method due to low 
cost, minimal amount of heparin needed and physiologic renal perfusion (Monnot et al 
2015).  
 
 
?
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?? ???????????????
The overall purpose of the study was to investigate the aspects of treatment of aortic 
infections involving biological grafts on the abdominal level and to evaluate a novel 
method of renal protection during complicated abdominal aortic surgery.  
 
The specific aims were: 
1. To evaluate the postoperative mortality and morbidity as well as long-term overall 
mortality after treatment of abdominal aortic infections with biological grafts (I–III). 
2. To study the long-term infection resistance of biological grafts after treatment of 
abdominal aortic infections (I–III). 
3. To study the midterm graft-related morbidity and mortality after biological conduit 
reconstructions due to abdominal aortic infections (I–III). 
4. To evaluate the efficacy of temporary axillo-renal bypass to prevent AKI in major 
aortic surgery. (IV) 
?
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?????????????? ???????
? ???????????????????????????
All studies were retrospective by nature, and data on patients was collected from hospital 
database and HUSVASC register in Helsinki, Finland. Studies I, II and IV were single-
centre studies conducted at Helsinki University Hospital and Study III was a multicentre 
collaboration. For the multicentre Study (III), retrospective data was acquired from 
hospital records in France, Italy, Switzerland, Denmark and Finland. In addition, Sweden 
provided data from prospective national SWEDVASC register. Causes of death were 
retrieved from Statistics Finland. The demographics and comorbidities of study patients 
are listed in Table 4. Additionally, perioperative details were collected, and known 
postoperative complications recorded. 
Table 4. Preoperative characteristics of patients 
COPD, chronic obstructive pulmonary disease; N/A, not available 
?
Diagnoses of AGI and MAAA were based on clinical symptoms (fever, abdominal/back 
pain, graft-cutaneous fistulas, GI-bleeding, concomitant infection), characteristic findings 
in at least one imaging modality, elevated inflammatory markers in laboratory analysis, 
 
 
 
Study I 
 
Study II 
 
Study III 
 
Study IV 
Number of patients 55 23 56 16 
Male (%) 42 (76) 15 (65) 46 (82) 13 (81) 
Age, median (range) 66 (51-82) 69 (24-87) 69 (35-85) 68 (31-80) 
Hypertension (%) 40 (73) 20 (87) 44 (79) 11 (69) 
Coronary heart disease (%) 20 (36) 10 (43) 17 (30) 5 (31) 
Diabetes (%) 23 (42) 9 (39) 16 (29) 2 (13) 
COPD (%) 6 (11) 9 (39) 12 (21) N/A 
Cerebrovascular disease (%) N/A 6 (26) 5 (9) 3 (19) 
Renal insufficiency (%) 2 (4) 5 (22) 9 (16) 9 (56) 
Cardiac insufficiency (%) N/A 3 (13) N/A N/A 
Immunocompromised (%) N/A N/A 16 (29) N/A 
Smoking (%) 23 (42) 11 (48) 31 (60) 3 (19) 
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and positive bacterial cultures from blood and/or intraoperative samples. Characteristic 
findings in CT or MRI included a perigraft abscess, air, pseudoaneurysm or AEF/AEE in 
case of an AGI; a saccular, multi-lobular, eccentric and rapidly growing aneurysm, 
periaortic soft tissue mass and gas for a MAAA. All suspicions were confirmed intra-
operatively: AGI as the presence of infective fluid around the graft, as the graft being 
totally unincorporated to the surrounding tissues or as the presence of AEE/AEF; and 
MAAA as pus and infection in aneurysm sac and surrounding tissues. Reinfection was 
defined as graft infection, graft rupture with sepsis, graft-enteric/aorto-enteric fistula, or a 
recurrent MAAA.  
The primary endpoints were 30-day mortality, overall treatment-related mortality, and 
reinfection rate. The secondary endpoints were long-term survival and graft-related 
morbidity (I–III). The impact of major aortic surgery on renal function was evaluated by 
means of the postoperative incidence of AKI and the outcome measures were 30-day 
renal function and mortality (IV). 
 
I 
 
All consecutive patients treated at HUH with aortic, aortobi-iliac or aortobifemoral graft 
resection and in situ FV reconstruction due to an AGI between October 2000 and March 
2013 were included in the study. Patients were identified from the hospital database by 
scrutinising all hospital admissions and outpatient clinic visits due to a postoperative 
infection or wound infection and from prospective HUSVASC register by identifying all 
patients operated on due to graft complications. Patients treated conservatively or by 
other operative means were excluded.  
Data from included 55 patients were collected from an electronic database and manually 
from patients’ charts. A two-team surgical approach was used: while one exposed 
infected graft, the other bilaterally harvested femoral veins from popliteal fossa to 
common femoral vein confluence. Side branches were doubly ligated, and, after graft 
eversion, valves were excised. After re-eversion, two grafts were sewn together into 
“pantaloon” configuration. After debridement, new aortic anastomosis was reinforced 
with autologous tensior fascia latae and graft covered with omentoplasty if possible. 
Femoral anastomoses were covered with sartorius myoplasty and intestinal defect, when 
present, reconstructed by a gastric surgeon. Postoperatively low-molecular-weight-
heparin (LMWH) and aspirin were administered, and intermittent pneumatic pumps used. 
Antibiotic treatment was prescribed by infectious disease specialist.  
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Patients were evaluated clinically one month after hospital discharge and radiologically 
6–12 months after discharge in order to assess graft patency and perigraft conditions. 
Synchronically laboratory tests were followed at the outpatient clinic of infectious 
diseases with possible adjustments to the antimicrobial medication and its duration. After 
one year, the follow-up was organised individually at the patient’s local hospital, with the 
intention of organising one radiological examination per year. 
 
II 
The study included patients who received cryopreserved large calibre venous allografts 
(CVA) (great saphenous veins excluded) for an arterial infection in suprainguinal area 
between February 2012 and March 2018. Patients were identified from the register of 
HUH Children’s Hospital Homograft Bank. Twenty-three patients treated with venous 
allografts were included in the study, whereas patients treated with arterial allografts for 
the same indications were reported separately in the Supplement (n=8). Reconstruction 
with femoral veins was performed in 21 (91%) patients, while 2 (9%) received vena cava 
grafts. Data on patients were retrieved from an electronic database.  
The HUH Homograft Bank cryopreserves vessels harvested from multiorgan donors by 
certified vascular surgeons. The freezing is temperature-controlled, and vessels are 
stored in nitrogen vapour at -180?C for up to 5 years. Thawing occurs in 37?C water bath 
for 30 minutes followed by cryoprotectant washout.  
At the implantation, the grafts side branches were doubly ligated and valves excised prior 
to the creation of the “pantaloon” or another graft configuration. Infected vessel or 
prosthetic graft was excised, area debrided, and new aortic anastomosis reinforced with 
fascia latae. Distal anastomoses were tension-free, but without reinforcement. 
Intracavitary grafts were covered with omentoplasty when possible and sartorius 
myoplasty was used in the groins. Postoperatively aspirin and LMWH were administered 
and antibiotics prescribed by an infectious diseases’ specialist.  
A clinical follow-up was organised one month after discharge, with radiological studies at 
6 months and one year. Thereafter annual radiological follow-up with CT or MRA for 
intracavitary grafts and triplex-ultrasound for extracavitary grafts, was recommended 
either at HUH or in a local hospital. The duration of antibiotic treatment was determined 
by an infectious diseases’ specialist based on haematological tests as well as the clinical 
status and radiological studies. 
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III 
All consecutive patients treated for abdominal or iliac mycotic aortic aneurysms in 
collaborating centres from January 2006 to December 2016 were identified. Electronic 
hospital databases were scrutinised in addition to the prospective registers of HUSVASC 
in Finland and SWEDVASC in Sweden. Fifty-six patients treated by means of biological 
in situ reconstruction were included in the study. The grafts used were: autologous FVs 
(n=30; 54%), cryopreserved arterial (n=7; 12%) or venous allografts (n=2; 4%), fresh 
allografts (n=5; 9%) or self-made XPTs (n=12; 21%). Patients treated with EVAR, 
prosthetic in-line reconstruction or AXBF were excluded as were patients who underwent 
biological reconstruction after an emergency bridge procedure with EVAR. Due to 
retrospective nature, the follow-up was not homogenised, but was rather individually 
designed by each collaborating centre.  
?
IV 
All major aortic surgery form catchment area of 2 million people, as well as oncovascular 
cases including aorta, vena cava or visceral vessels from all of Finland, are performed at 
HUH. In less than 2% of these cases have we needed efficient renal protection due to 
potentially long suprarenal cross-clamping time or impaired renal function. Therefore, we 
have used extracorporeal axillo-renal bypass for temporary renal arterial perfusion in 
selected cases with following indications: preoperative renal insufficiency, one 
functioning kidney, renal transplant or expected long suprarenal clamping time due to 
scar tissue, a congenital tissue defect, concomitant renal artery stenosis or other 
anatomical challenge.  
Between October 2007 and May 2012, sixteen patients underwent temporary axillo-renal 
bypass during suprarenal aortic clamping. Two-team approach was used with one team 
preparing the axillar prosthetic inflow-graft with necessary amount of outflow branches, 
while other team dissected visceral aorta and renal vessels. Prior to aortic clamping, an 
end-to-end anastomosis between the renal artery and prosthesis was made for one renal 
artery requiring perfusion. If both were perfused, Y-shaped prosthetic graft limbs were 
first anastomosed one renal artery at the time prior to aortic clamping (Figure 5). Renal 
perfusion was confirmed with flowmetry. After aortic reconstruction, temporary graft was 
truncated and implanted into the aortic prosthesis. Axillar stump was oversewn. 
Postoperatively, SCr and urine output were measured, and acute renal failure evaluated 
based on RIFLE (Risk, Injury, Failure, Loss of renal function, End stage renal disease) 
criteria. At 30-day clinical follow-up SCr and estimated GFR were determined.  
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?
?
? ????? ?
Figure 5 Temporary axillo-birenal bypass during aortic surgery (A) and after truncation (B).3 
? ??????????????????????
For statistical analysis SPSS packages 19.0 (SPSS Inc, College Station, TX, USA) (I, IV) 
and 22 (IBM, Armonk, NY, USA) (II, III) were used. Continuous variables are expressed 
as median (range) and categorical variables as proportions (%). Univariable analysis was 
performed to analyse the associations of risk factors (age, comorbidities and operative 
details) with early, treatment-related and overall mortality using the chi-squared test and 
unadjusted proportional hazards model (I), Fisher’s exact test (II, III), and the Kruskal-
Wallis test (II). Binary logistic regression was applied to determine risk factors associated 
with treatment-related mortality (III, IV) or postoperative renal failure (IV). The 
multivariable Cox regression analysis for overall survival (I, III) and graft thrombosis (II) 
were performed. The survival was calculated with Kaplan-Meier method (I–III). All 
statistical tests were two-tailed, and p < 0.05 was considered statistically significant.  
                                                 
3 Heinola I, Halmesmäki K, Kantonen I, Vikatmaa P, Aho P, Lepäntalo M, Venermo M. Temporary Axillorenal Bypass in Complex 
Aorto-Renal Surgery. Ann Vasc Surg. 2016 Feb;31:239-45. With permission by ELSEVIER Inc.  
A B 
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????????
? ?????? ????????????? ???????????????
?????????????????????????????????????????
?????????????????????????????????????????
During the early postoperative period 35% (46/132) of the patients needed a reoperation: 
this involved 36% of the AGI patients treated with FVs (I), 43% of patients whose aortic 
infection was treated with cryopreserved allografts (II) and 29% of patients with a MAAA 
treated with biological grafts (III). The most common indications for the operation were 
lower limb ischaemia and GI complications including bowel necrosis and intestinal 
leakage after AEF repair. Non-surgical complications occurred in 26% (34/132) of the 
cases, constituting; 20%, 39% and 25% in Studies I, II, III, respectively, with renal 
dysfunction being the most prevalent (13%–19%). A total of 17 (13%) patients required 
renal replacement therapy and 3 (2%) of them permanently. Two FV grafts and one 
cryopreserved vein graft ruptured –one FV due to size mismatch and tension in the 
proximal anastomosis, other FV and CVA due to reinfection. Operative details and 
postoperative complications are listed in Table 5.  
The 30-day mortality was 9% for patients treated with FV for an AGI (I); 9% for patients 
treated with cryopreserved allografts for mixed indications (II); and 5% for patients who 
received mixed reconstruction materials due to a MAAA (III). None of the deaths were 
directly graft-related but were rather disease-related and due to postoperative 
complications. The 30-day and in-hospital mortality rates in patients treated due to AEF 
were 10% and 20%, respectively, compared to the respective 9% and 10% in patients 
treated due to non-AEF-related AGI; the respective 5% and 8% in patients operated on 
for a MAAA.  
?
?
?
?
?
?
?
?
?
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Table 5. Perioperative details, postoperative complications (grey background) and 30-
day mortality after in situ biological reconstruction due to aorto-iliac infections. 
Rec, reconstruction; vasc, vascular; AEF, aorto-enteral fistula; AEE, aorto-enteral erosion; GI, 
gastrointestinal; op, operation; RRT, renal replacement therapy 
?
? ????????????????????? ????????????????????????????
?????
Bacterial cultures from tissue or blood were positive in 74% (n=98/132) of all cases – 
71%, 70% and 77% in Studies I, II and III, respectively. The most commonly isolated 
bacteria were Staphylococcal strains in all series; however, virulent Staphylococcus 
aureus was predominant in cohorts operated on due to a MAAA (III) or mixed infectious 
 
Variable, n (%) 
 
Study I 
 
Study II 
 
Study III 
Number of patients 55 23 56 
Intracavitary rec  15 (27) 7 (30) 56 (100) 
Intra- and extracavitary rec  40 (73) 11 (48) - 
Extracavitary rec - 4 (17) - 
Concomitant vasc rec / other 4/9 (7/16) 8/4 (35/17) 13/3 (23/5) 
AEF and AEE 8 (33) 2 (9) - 
Rupture 1 (2) 5 (22) 12 (21) 
Reoperations due to graft rupture 2 (4) 1 (4) - 
       Other bleeding - 2 (9) 6 (11) 
       Ischaemia / graft thrombosis  8/4 (15/7) 1/- (4/-) 2/- (4/-) 
       GI complication  6 (11) 3 (13) 4 (7) 
Amputation, primary op / reoperation  1/3 (2/5) - -/1 (-/2) 
Renal dysfunction  9 (16) 3 (13) 9 (16) 
       RRT, temporary / permanent 5/- (9/-) 2/1 (9/4) 7/2 (13/4) 
Cardiac complications  6 (11) 2 (9) 2 (4) 
Stroke  1 (2) 1 (4) 1 (2) 
Early graft reinfection  1(2) 1 (4) - 
30-day mortality  5 (9) 2 (9) 3 (5) 
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indications (II). Coagulase-negative staphylococci were the most prevalent among 
patients treated with FV for an AGI, closely followed by Staph. aureus (I). Polymicrobial 
growth was detected in 19% (n=25/132) of all cases; with 33%, 17% and 7% in Studies 
I, II and III, respectively, being most common among patients treated for AGI and AEF. 
The most frequently isolated bacteria are listed in Table 6.  
?
Table 6. Isolated microorganisms 
?
?
As mentioned before, two graft reinfections appeared during the early postoperative 
period, and one during the later phase, constituting a reinfection rate of 2% (3/132) 
among all biological reconstructions. One FV reconstruction became reinfected in a 
constantly septic patient, who was primarily treated with EVAR for a MAAA. He 
 
 
 
Study I 
 
Study II 
 
Study III 
Positive microbial growth, n (%) 39 (71) 16 (70) 43 (77) 
Polymicrobial growth, n (%) 18 (33) 4 (17) 4 (7) 
Monomicrobial growth, n (%)  21 (38) 12 (52) 39 (70) 
Coagulase-neg Staphylococcus spp 10 2 - 
Staphylococcus aureus / MRSA 6/1  5/- 15/3 
Streptococcus spp 5  3 7 
Escherichia coli 3  3 5 
Candida spp 5 1 2 
Salmonella spp - - 10 
Pseudomonas aeruginosa 4 2 - 
Enterobacteriaceae spp 4 1 - 
Bacteroides fragilis 4 - 1 
Enterococcus spp  2 1 - 
Staphylococcus lugdunensis  - 2 - 
Prevotella  1 2 - 
Lactobacillus 3 - - 
Klebsiella  2 - - 
Campylobacterium spp - - 2 
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developed an early AEF with concomitant discitis and was therefore treated with 
endovascular graft explant and in-line reconstruction. He had dispersed intestinal 
necrosis and peritonitis while his FV graft ruptured due to reinfection. Despite a 
successful reoperation, he died on the 37-th postoperative day due to mesenteric 
ischaemia. Second early graft reinfection occurred after aortobifemoral CVA rupture 
reconstructed due to a late AGI. The patient underwent a graft limb re-reconstruction with 
a new CVA due to graft contamination with Candida. However, re-ruptures appeared in 
different parts of the graft and patient required re-reconstructions until antifungal 
medication eliminated bloodborne spread after which the grafts remained intact. Third 
reinfection appeared two years after an aortobifemoral FV reconstruction due to an AEF. 
Recurrent AEF developed and was treated with palliative EVAR due to patient’s poor 
general condition. The patient died of a GI haemorrhage three months later. No 
reinfections emerged among patients treated for MAAA.  
Isolated strains and susceptibility determined the antibiotic therapy when available. In 
case of negative cultures, antimicrobial therapy was broad-spectrum. The duration 
depended on the virulence of isolated strains, severity of the infection and postoperative 
course. The median duration was 12 weeks (range 3–85 weeks) in a cohort treated for 
mixed suprainguinal arterial infections (II) and 8.5 weeks (range 1–35 weeks) among 
patients treated for MAAA (III). None of these patients needed life-long medication. The 
median duration of antimicrobial therapy was not evaluated among patients treated with 
FV for AGI; however, the suppression was necessary for two patients as a consequence 
of partial graft preservation (I). 
???
? ??????????????????? ????????????? ???????
???????????????????????
In addition to reinfections, stenotic complications and occlusions, anastomotic dilatation 
and pseudoaneurysms occurred causing graft morbidity. During the follow-up period, 
14/132 patients required graft reinterventions, with stenosis as the most frequent 
indications. (see all details in Table 7) Stenotic complications appeared only in 
autologous FV grafts (n=9), two of which occluded. Third occlusion occurred without 
underlying stenosis (n=10/85 FVs; 12%). Reinterventions were performed for 
symptomatic or hemodynamically significant stenosis found in follow-up studies. 
Percutaneous transluminal angioplasty (PTA) was sufficient in all cases, with the 
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exception of one that required thrombectomy. One graft occluded after several 
angioplasties and was diverted with femoro-femoral crossover bypass. One graft limb 
occluded silently after initial angioplasty as a result of a common femoral artery occlusion. 
Few months later, ipsilateral native iliac arteries were recanalized during a hybrid 
procedure for critical limb ischaemia, possible due to previous end-to-side upper 
anastomosis. One anastomotic pseudoaneurysm among FV graft recipients was stented 
and another operated on, but latter patient died due to postoperative pulmonary 
embolism (I, III). 
None of the seven cryopreserved arterial allografts showed any complications in 
treatment of MAAAs (III). Among the cryopreserved venous allografts, one aneurysmatic 
anastomotic dilatation was operated on with prosthetic interposition and one 
pseudoaneurysm stented percutaneously (n=2/23 CVAs; 9%). No association between 
graft complications and ABO-incompatibility existed (p=0.743) (II). 
Table 7. Long-term graft-related morbidity (grey background) and mortality.  
 
  
Study I 
 
Study II 
 
Study III 
Number of patients 55 23 56 
Follow-up months, median (range) 32 (1–157) 15 (3–62) 26 (3w–172mo) 
Graft occlusions, n (%) 2 (4) - 1 (2) 
Graft stenosis, n (%) 7 (13) - 2 (4) 
Anastomotic 
aneurysm/pseudoaneurysm, n (%) 
 
2 (4) 
 
2 (9) 
 
- 
Graft patency, primary/secondary  84% / 96% 100%/100% 95%/100% 
Freedom from graft reinterventions  78% 5 y 87% 2 y 95% 5 y 
Treatment-related mortality, n (%) 10 (18) 3 (13) 5 (9) 
Overall mortality during follow-up,n (%) 22 (40) 6 (26) 11 (20) 
Kaplan-Meier survival for 1 year  82% 76% 83% 
    (95% confidence interval) (71%–92%) (57%–95%) (73%–94%) 
Kaplan-Meier survival for 2 years 76% 70% 81% 
    (95% confidence interval) (65%–88%) (49%–91%) (70%–92%) 
Kaplan-Meier survival for 5 years 59% - 71% 
    (95% confidence interval) (43% - 73%)   (52% - 89%) 
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There were no graft-related complications among patients treated with self-made bovine 
pericardium tube grafts (n=12) and fresh arterial allografts (n=5) (III). At the end of follow-
up, all but two femoral vein grafts remained patent, and only one patient underwent 
amputation as a result of critical limb ischaemia with a patent aortic graft.  
The overall treatment-related mortality during the study period was 18% after treatment 
of AGIs with FVs (I), 9% after treatment of MAAAs with biological graft (II) and 9% after 
treatment of mixed infections with CVAs (III). The Kaplan-Meier estimate for 5-year 
survival in the studies I and III was 59% and 71%, respectively; due to a small number of 
patients, only 2-year Kaplan-Meier survival estimate was calculated in Study II (Table 7, 
Figure 6).  
 
  
Figure 6 Kaplan-Meier curve demonstrating the overall survival for patients treated with 
autologous veins due to an aortic graft infection (Study I); with cryopreserved venous 
allografts due to various suprainguinal arterial infections (Study II); and with different 
biological materials for a mycotic abdominal aortic aneurysm (Study III).  
For patients treated due to MAAA, univariate analysis revealed need for renal protection 
during suprarenal clamping (p=0.15), duration of the operation (p=0.046) and CRP at the 
time of diagnosis (p=0.049) as predictive factors for treatment-related mortality. Smoking 
(p=0.034) was associated with higher total mortality, and a negative bacterial culture 
(p=0.026) was associated with lower mortality. In multivariable analysis, smoking (hazard 
ratio ?HR? 10.1; 95% CI, 1.09–92.96; p=0.042) and CRP level at diagnosis (HR 1.1 for 
??????????? 
???????? ?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? 
?????????? ??????????? ???????????????????????????????? 
?????????? ????????????????????????????????????????????????????????????????????????????????????????????????????????????????????????? 
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every 10 units; 95% CI, 1.02–1.15; p=0.013) were associated with all-cause mortality 
(III). 
For patients treated with CVA for suprainguinal arterial infection, heart failure was 
associated with all-cause mortality based on the univariable analysis (p=0.019) (II). 
In AGI cohort treated with autologous veins no statistical association appeared with 
mortality (I). 
 
? ?????????????????? ?????????????????????
??????????????????
The most common indication for surgery was juxta- or suprarenal aneurysm (n=11/16, 
69%; see details and results in Table 8). Preoperative renal function was normal in 44% 
(n=7/1) of the patients and moderately impaired in 56% (n=9/16). Temporary bypass was 
reconstructed foe a single kidney in 7 (44%) cases and bilaterally in 9 (56%) cases. The 
median operation time was 393 minutes and the median cumulative renal ischaemia time 
was 24.5 minutes. Despite considerably safe renal ischaemia time, kidney function 
deteriorated in six (38%) patients, and two (12.5%) suffered temporary renal failure, one 
of which required RRT for five days. However, all patients survived the postoperative 
period, and renal function had stabilised to preoperative level or improved in all cases at 
the 30-day follow-up. Statistical analysis revealed no significant factors associated with 
postoperative kidney injury.  
The axillar dissection area caused no extra morbidity and healed per primum in all cases.  
?
?
?
?
?
?
?
?
?
?
?
?
?
?
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Table 8. Patients who underwent temporary axillorenal bypass and postoperative measures  
AAA, abdominal aortic aneurysm; CIAA, common iliac artery aneurysm; CLI, critical limb ischaemia; F, 
female; eGFR, estimated glomerular filtration rate; IIAA, internal iliac artery aneurysm; M, male; N/A, 
not available; RA, renal artery; SCr, serum creatinine (?mol/l); Uop, urine output (ml). Bold figures 
highlight the results that defined RIFLE category. 
?
Age/
Sex 
 
Indication 
Renal 
clamp 
time 
(min) 
Preop 
SCr/ 
eGFR 
 
 
Postop 
SCr/Uop 
 
RIFLE 
Follow-up 
SCr/ eGFR 
58/F 
Intra-abdominal 
myofibroblastic tumour, 
recidive 8 67/82 
 
 
80/2,110 
  
 
58/95 
71/M 
RA stenosis (kidney 
transplant), AAA, CIAA, 
IIAA (transplant side) 26 146/47 
 
 
142/1,930 
 
94/71 
60/M 
Suprarenal AAA. Renal 
tumour on the right side. 16 202/40 
 
227/2,080 
 
141/60 
58/F 
Aortic occlusion with 
claudication. Takayasu 
arteritis. 24 80/104 
 
 
88/1,280 
 
52/161 
62/M 
Bilateral CLI. Infrarenal 
AAA, RA stenosis (kidney 
transplant) 29 75/79 
 
 
112/2,245 
 
77/77 
71/M 
 
Bilateral renal artery 
stenosis. Infrarenal AAA. 16 111/59 
 
 
103/1,250 
 
74/88 
76/M 
Suprarenal AAA. Thoracic 
and infrarenal aorta 
previously reconstructed. 25 81/76 
 
 
86/2,120 
 
85/76 
66/M 
 
Suprarenal AAA 15 132/61 
 
177/1,080 
 
112/71 
73/M 
Suprarenal AAA. Infrarenal 
aorta previously 
reconstructed. 20 126/63 
 
 
127/820 
 
 
Injury 110/73 
74/M 
Juxtarenal AAA. RA 
stenosis (single functioning 
kidney) 50 171/36 
 
 
249/1,475 
 
 
Risk 186/33 
47/M 
Suprarenal AAA, bilateral 
CIAAs. Marfan's syndrome. 
Status post B type 
dissection. 29 78/132 
 
 
 
83/1,443 
 
82/125 
74/M 
 
 
Suprarenal AAA 24 160/39 
 
148/565 
RRT  
 
 
Failure 100/62 
58/M 
 
Suprarenal AAA 39 93/101 
 
184/1,695 
 
Risk 136/69 
80/M 
Suprarenal AAA contained 
rupture. Pelvic kidney. 32 52/106 
 
116/269 
 
Failure 70/79 
70/F 
 
Suprarenal AAA 36 110/60 
 
101/915 
 
73/91 
31/M 
Symptomatic suprarenal 
AAA. Marfan's syndrome. 17 101/125 
 
188/1,515 
 
Injury 
 
N/A 
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? ?? ????????? ????????????
The main limitation of the study is the lack of comparison between biological 
reconstructions and other treatment methods used for aorto-iliac infections. Herein, the 
entity of aortic infections comprises of AGIs and MAAAs, which are different in etiology, 
pathophysiology and bacteriology and a prospective comparative study should therefore 
be implemented separately for both to provide high-quality results. However, due to low 
incidence of these conditions per institution, a vast multicentre collaboration is needed, 
which, in turn, hampers the organisation of uniform management and the 
homogenisation of the follow-up. Patients with advanced age, severe systemic diseases 
and a variety of complications due to aortic infections are extremely difficult to randomise, 
making recruitment slow and ineffective. Gaining high-quality results from such 
demanding setting would take an extremely long time and, entails the risk of the 
treatment methods under comparison becoming obsolete. In case of Study III, only a 
handful of patients with MAAA were treated with other methods besides in situ biological 
grafts at the other collaborating centres except in Sweden. During the study period 70 
EVAR implants out of 80 (88%) were performed in Sweden due to MAAA, as well as 41 
in situ prosthetic reconstructions out of 51 (80%). The results of these SWEDVASC 
patients treated with EVAR or in situ prosthetic grafts during a time span of 8 years 
overlapping with Study III were published by Sörelius and are therefore considered 
somewhat comparable (Sörelius et al 2016).  
The retrospective nature of the study also contains the risk of case selection and 
selection bias. Reliable data on patients treated conservatively (II, III) did not exist, or 
patients treated with suprarenal clamping and without a renal protection method were 
not extracted (IV). However, in Study I, all 73 patients treated for AGI during the selected 
time period were revised, and 18 were excluded from the study. Nine out of 18 patients 
were treated conservatively due to poor general condition or a localised, nearly 
asymptomatic infection. In seven cases, local debridement was performed due to the 
patient’s advanced age and comorbidities, while one patient was treated with prosthetic 
in-line reconstruction due to haemorrhagic shock and one reconstruction was performed 
with fresh allografts due to the patient’s refusal of FV harvesting.   
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In addition, the retrospective nature of the study makes it impossible to acquire missing 
data, such as hospital stay in a local facility (I–III) or results of missing laboratory analysis 
(IV) and to standardise follow-up protocols (III). 
In Study IV the follow-up comprised only early postoperative period, and, therefore, the 
associations of postoperative AKI and development of CKD with risk of higher long-term 
mortality cannot be determined. 
The relatively small number of patients in all studies set limitations to the statistical 
analysis and compromises the results.  
 
? ??????????????????????????????????????
Biological-material is not as susceptible to bacteria as prosthetic material. Total 
endothelial coverage of FV grafts and scattered coverage of cryopreserved allografts 
protects them from bacterial attachment. Furthermore, nutrients, oxygen and antibiotics 
are capable of diffusing into the vessel wall and through it to the perigraft tissue. (Moore 
et al 1980, Kieffer et al 2004.) Three reinfections occurred during the current study; two 
grafts became reinfected after treatment for an AEF, and one Candida-colonized 
cryopreserved allograft ruptured due to a reinfection (I, II).  
An invasion of Candida into the bloodstream after endothelial adhesion is difficult to treat. 
Adhesion depends on the virulence factors present, but predilection to abnormal intima 
may place allografts at risk (Mai et al 2006, Sanchez et al 2004). Candida is part of 
intestinal microflora and can be transferred via AEF, or the colonisation can be a result 
of a recipient-borne complication due to antimicrobial suppression and diminished host 
resistance. Candida has been associated with higher early mortality and has been 
speculated to be associated with graft rupture (Vogt et al 2002, Matsuura et al 2002, Ali 
et al 2009, Lejay et al 2017). Therefore, a high suspicion of concomitant fungal infection 
in patients on prolonged antibiotic medication, and involvement of multi-disciplinary team 
in the management of these complex patients are mandatory to improve the outcome (Ali 
et al 2009, Lyons et al 2016, Lejay et al 2017).  
Two other patients who suffered FV reinfection after the treatment of AEF, had 
polymicrobial intestinal flora in bacterial cultures and required extensive aortobifemoral 
reconstructions. One on them was already in severe sepsis after primary endovascular 
stenting of a MAAA and did not recover even after conversion to in situ reconstruction 
with FVs. Candida, and virulent gram-negative bacteria as predictive factor for graft 
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complications, were cultured from the graft (Harlander-Locke et al 2014, Lejay et al 
2017). The other patient had rather mild symptoms, but suffered Candida-induced sepsis 
prior to AGI diagnosis, possibly indicating an immunocompromised state (I).  
However, the reinfection rate of 2% remains extremely low, and shows better infection 
resistance in comparison prosthetic reconstructions without strict preselection. Sörelius 
reported reinfection rate of 18% after prosthetic in situ reconstructions for mycotic aortic 
aneurysms and of up to 27% after EVAR (Sörelius et al 2014 and 2016). A reinfection 
rate of 11% has been reported after in situ prosthetic repair for AGI. Among selected 
patients with low-grade infection and no gross purulence, it can be diminished to 4% 
.(Batt et al 2003, Oderich et al 2006 and 2011.)  
Other series have reported reinfections in 0%–5% of patients after aortic reconstructions 
with CAAs and FVs (Daenans et al 2003, Ali et al 2009, Harlander-Locke et al 2014, 
Touma et al 2014, Ahmed et al 2017). Until recently, no infectious complications had 
occurred among XPT recipients, but the latest paper by Lutz reported 2 ruptures due to 
reinfections in a cohort of 13 patients (Czerny et al 2011, Weiss et al 2017, Lutz et al 
2017). No reinfections emerged among XPT recipients in the current cohort, but despite 
the infection resistance, data on graft durability is lacking and considered approach is 
therefore recommended until further research (III). 
 
? ?????????????????
The synthetic materials of prosthetic grafts are resistant to breaking and degradation 
despite robust handling or bacterial presence. Furthermore, large diameter warrants 
patency, resulting in extremely low amputation rates (Batt et al 2003, Oderich et al 2011, 
Frei et al 2011). Biological grafts, however, react to handling and implantation with 
several mechanisms. Autologous FVs are immunologically excellent, but patency is 
altered by stenotic lesions. Intimal hyperplasia and remodelling, as well as chronic 
inflammatory endothelial cell activation caused by elevated shear stress in arterial 
position, may result in stenotic lesions similar to graft stenosis in lower-limb saphenous 
vein bypasses (Ward et al 2017). Heavy smoking, graft diameter of < 7.2 mm and 
clinically significant coronary artery disease seem to be associated with stenotic 
complications. The relative risk of stenosis is doubled with every one-millimetre decrease 
in graft diameter. Moreover, smaller grafts present with stenotic complications in earlier 
phase. (Beck et al 2008.) In current study, FVs of > 6mm were accepted as reconstruction 
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material, and the smaller diameter may therefore have contributed to the 10.6% 
incidence of stenotic complications among FV recipients in current cohort compared to 
8.3% in cohort reported by Beck (I, III) (Beck et al 2008). 
The durability of cryopreserved grafts has improved with advanced cryopreservation 
techniques, but the amount of graft-related non-infectious complications ranges from 
5%–55% (Vogt et al 2002, Bisdas et al 2010, Harlander-Locke et al 2014, Heo et al 2017, 
Lejay et al 2017). Cryopreservation modifies the antigenicity of vascular grafts, but some 
degree of recipients’ cellular and humoral response still exists (Mirelli et al 2005). 
Immunogenicity is affected by HLA complexes presented by endothelial cells and SMCs, 
which cryopreservation methods aim to preserve for better patency (Rendal et al 2004). 
Freezing and thawing still cause some degree of endothelial denudation, furthermore, 
they carry a risk of elastic fibre fragmentation and loss of wall tensile strength. Therefore, 
freezing process must be temperature-controlled and thawing slow. (Pegg et al 1996, 
Müller-Schweinitzer 2009.) The SMC layer is thicker in arteries and the immunologic 
response is thus thought to be more potent compared to veins. After a few thrombotic 
complications of arterial allografts (II, supplement) and some atherosclerotic 
degenerations of peripheral grafts (unpublished data), cryopreserved venous allografts 
became the preferred reconstruction material at HUH. Vein calibre is larger due to thin 
vessel wall, and, therefore, “pantaloon”-grafts reconstructed from two femoral vein 
allografts offer a more suitable diameter for aortic anastomosis, than grafts created out 
of two femoral arteries. Another contributing factor could be lack of endothelium, and 
therefore, fewer antigen-presenting cells and lesser immunological reaction (Aavik et al 
2008). We have studied cryopreserved venous allografts prior to implantation and found 
no luminal endothelium present. Despite a denuded luminal surface, large calibre and 
large flow volume maintained graft patency of all venous allografts in current study (II). 
However, one anastomotic aneurysmal dilatation and one pseudoaneurysm call for 
further research in cryopreservation techniques and graft handling to avoid elastic fibre 
fragmentation. Furthermore, to secure a proximal anastomosis, thin valve pockets should 
be excised and circumferential outer support with fascia latae used. With this technique, 
no proximal anastomotic complications appeared. Moreover, reinforcement of distal 
anastomosis in the future should be considered, since two distal dilatations developed in 
current study. (II)  
The durability of fresh allografts is inferior to that of cryopreserved allografts, and caution 
is warranted despite the excellent performance in the current cohort (III) (Kieffer et al 
2004). 
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Aortic infection is physiologically exhausting and requires extensive surgery to achieve 
bacterial eradication and to cure the infection. Patients present with sepsis, acute limb 
ischaemia, AEFs, rupture and concomitant infections, and they are frequently 
immunocompromised and nutritionally depleted, making the risk of early mortality 
considerable. To minimise the risk of early and late mortality, patients have to be 
evaluated individually and managed with tailored treatment.   
In situ reconstructions have outperformed the extra-anatomical bypass in every aspect 
(Batt et al 2018). AXBF has been recommended in case of an AGI with Pseudomonas, 
MRSA or multidrug-resistant pathogens, since metastatic microabscesses have been 
found in the proximal aorta of Pseudomonas-patients. However, the same reason raises 
the risk of stump blowout and subsequent mortality. (Geary et al 1990, Wilson et al 2016.) 
In current study, seven patients presented with Pseudomonas infection and one with 
MRSA. One of them died due to sepsis during the early postoperative period, but none 
developed infectious graft complications (I, II). In rare cases, MAAA patients presenting 
with concomitant discitis or psoas abscesses and constant sepsis, may benefit from 
extra-anatomical reconstruction (Wilson et al 2016). 
In situ reconstructions with rifampicin-soaked prostheses, silver-prostheses and FVs 
carry similar early mortality rates of 10%–12%. Reconstructions with CAAs express a 
slightly higher mortality of 22%. However, biological grafts have the advantage in late 
survival. (Batt et al 2108, Smeds et al 2014.) In current study, the postoperative mortality 
was as low as 5% for patients treated for MAAA (III), 9% for patients treated for AGI (I) 
and 9% for patients treated for mixed infectious indications (II). Patients who undergo 
surgery due to an AGI have more severe atherosclerotic risk factors, have already been 
operated on due to atherosclerotic complications and may present with an AEF. AGI 
operations are performed in scar tissue, reconstructions are more extensive and 
technically more demanding than operations for MAAAs, which might explain the higher 
mortality among patients with AGI. Furthermore, there is possibility for case selection in 
Study II. Our preferred reconstruction material has been FV, but to diminish surgical 
trauma on very severely ill individuals, we have implanted cryopreserved allografts rather 
than FVs in case of fragile patients with severe comorbidities, making cryopreserved the 
allograft cohort the highest-risk group for complications and mortality.   
The estimated 5-year survival of 71% in patients treated for MAAAs (III) is comparable 
to survival of patients treated for elective degenerative AAAs with open repair and EVAR 
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(75% and 67%, respectively) (Laine et al 2017). EVAR does not yield a significant 
advantage in early survival, compared to Study III, and the survival of 58% at 5 years 
remains inferior (Sörelius et al 2014). Therefore, for MAAA patients fit for open surgery, 
mycotic aneurysm resection and in situ reconstruction with biological material should be 
considered. If they are treated with EVAR, close surveillance and extremely low threshold 
for conversion is recommended.  
Patients treated for AGI had a 5-year survival of 59% (I) and patients treated for mixed 
indications a survival of 70% at two years (II). Both cohorts included patients with AEFs, 
who are generally sicker, have polymicrobial infections and are often in need of an urgent 
operation due to sepsis, GI bleeding or graft limb thrombosis. In several series of AGIs, 
patients who died postoperatively are the ones with AEF. The early mortality varies from 
8%–9% in some series to up to 43%–57% in others % (Ali et al 2009, Oderich et al 2011, 
Batt et al 2011). Oderich reported a 5-year survival of 59% after in situ rifampicin-soaked 
prosthetic reconstruction in a somewhat selected AEF cohort (Oderich et al 2011). 
However, without preselection, long-term survival remains significantly lower – 11%–
18% (Ali et al 2009, Batt et al 2011). For 18 patients with an AEF in Study I, in-hospital 
mortality was 22% and 5-year mortality 44%. Both patients who developed reinfections 
in Study I initially presented with an AEF. 
 
? ??????????????????????
Major aortic surgery encompassing visceral arteries poses a risk of postoperative renal 
dysfunction. Acute ischaemic kidney injury, a common complication in vascular surgery, 
is associated with higher postoperative and total mortality, as well as development of the 
CKD (Sailer et al 2016, Zarkovsky et al 2016). Therefore, any preventive method to 
diminish renal ischaemia time is justified.  
A clamp-and-sew technique is accepted when anatomical challenges are not expected. 
However, when ischaemia is prolonged to over 25 minutes and patient has underlying 
renal dysfunction, protection should be considered (Yeung et al 2016, O’Donnell et al 
2018). Cold renal perfusion is preferred due to availability and ease of use. Yeung 
reported a mean renal ischaemia time of 37 minutes to be safe with no postoperative AKI 
in elective setting (Yeung et al 2008). Nevertheless, the median ischaemia time of 24.5 
minutes in current cohort led to AKI in six cases, indicating the possibility that in complex 
patients, development of AKI is hard to predict and depends on more factors than solely 
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ischaemia. When anatomical challenges propose the prolongation of clamping time, 
patient already has underlying renal disease or a kidney transplant, temporary bypass 
lowers the risk of renal damage providing physiological perfusion that can be confirmed 
perioperatively with flowmetry or triplex ultrasound. In case of renal transplant, we find 
axillary bypass directly to renal arteries, with subsequent shunt implantation to aortic 
prosthesis, a more elegant solution than temporary axillo-femoral bypass. End-to-end 
renal bypass provides pulsatile flow with adequate pressure, and subsequently created 
aorto-renal bypass protects the renal arteries from further extension of atherosclerotic 
disease. Furthermore, femoral cut-down predisposes to a higher risk of wound infection 
compared to proximal axillar incision (Szilagyi et al 1972). One might argue that 
additional bypasses prolonging the operation are unnecessary, if cold perfusion only 
takes minutes to start. However, if an additional surgeon is recruited, bypass can be 
reconstructed synchronically, and extra time is spent on visceral anastomosis only. 
Temporary bypass affords time to adopt a meticulous technique in creating the aortic 
anastomosis and allows additional manoeuvres when unexpected difficulties appear in 
case of complicated anatomy, tumour resection or congenital tissue defects. We aim to 
use cold perfusion in suprarenal reconstructions in patients without renal impairment. 
Nevertheless, due to renal artery ostial stenosis or, vice versa, large arteries with 
constant dislocation of catheters, we frequently end up using a clamp-and-sew 
technique, when temporary bypass is not indicated. 
In addition to renal arteries, five superior mesenteric arteries were concomitantly shunted 
to minimize the global ischaemia-reperfusion insult. Mesenteric ischaemia lasting over 
40 minutes is associated with vast inflammatory reaction and multiorgan failure (Hanssen 
et al 2008, Monnot et al 2016).  
Since temporary bypass is used extremely rarely, patients at higher risk of complications 
and mortality were selected to current study. Despite the more gravely ill cohort, all 16 
patients survived postoperative period.  Moreover, in case of three patients, preoperative 
renal impairment was normalised.  
?
? ????????????????????
To diagnose abdominal aortic infections, one has to understand the criteria defining 
them. Protean manifestations and ambiguous results in laboratory tests and radiological 
studies require a consensus to differentiate between “not likely”, a suspicion and a 
confirmed diagnosis. The MAGIC collaboration defined diagnostic criteria for AGIs in 
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2016, but a similar document for MAAAs is lacking (Lyons et al 2016, Sörelius et Di 
Summa 2018). Due to complexity of the disease, prospective comparative studies will 
most likely never be possible which is why we need to improve the quality of the results 
by homogenising the patients included in the series to develop the recommendations for 
diagnostics and management. Due to rarity of the condition, prospective international 
registries could provide standardised data on management of such patients and further 
contribute to evidence-based recommendations. The MAGIC-database has been 
created to collect prospective data on AGI patients, however similar database for MAAA 
patients is lacking (Lyons et al 2016).  
Biological aortic reconstruction material is infection-resistant, however long-term 
durability could be improved. Further research on cryopreservation techniques and 
suppression of immunology of the arteries could improve the results. Decellularized 
grafts provide an immunologically compatible alternative, with immunogenic cells 
removed and acellular matrix ready to be repopulated by recipient cells. Promising results 
from cardiac surgery have raised interest, however, current decellurisation methods 
accelerate elastin fragmentation and, therefore, aneurysmal degeneration appears after 
the implantation of such grafts into high-pressure arterial system. Tissue engineering, 
such as combining decellularized allografts with synthetic polymers, may result in more 
durable grafts, as might seeding the decellularized allograft’s scaffold with luminal 
vascular cells prior to implantation. (Martin et al 2005.) 
Cryopreserved large-calibre venous allografts showed promising results in current study; 
however, fragmentation and slow aneurysmal dilatation at the anastomotic sites may still 
appear. Further research on developing cryopreservation methods designed for veins 
are warranted. Denuded endothelium diminishes the immunogenicity but does not 
promote thrombogenicity. Creating freezing-thawing protocols and handling techniques 
that spare elastic fibres from deterioration would make cryopreserved large-calibre 
venous allografts a very promising biological reconstruction material for the aorta.     
XPTs as aortic reconstruction material are very appealing due to availability, scaffolding 
and cost. They are infection-resistant and results regarding their durability are anticipated 
with excitement to ascertain their position in infectious conditions.   
The prevention of AKI remains one of the most important factors to be addressed in aortic 
surgery encompassing renal arteries. Comparative studies of renal protection methods 
in major aortic surgery could identify patients who benefit from physiological perfusion 
the most and provide prognostic data for determining whether different renal protections 
have any effect on early mortality, or development of CKD and overall survival.  
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1. Postoperative morbidity remains high after surgical treatment of abdominal aortic 
infections. The mortality, however, is at acceptable level in multidisciplinary team 
approach. An aorto-enteric fistula as an indication for surgery carries the highest 
risk of morbidity and mortality irrespective of the reconstruction material used.   
In terms of midterm mortality, treatment of mycotic abdominal aortic aneurysm 
with biological conduit is not inferior to standard treatment of infrarenal 
degenerative aneurysm. The overall mortality after aortic graft infections remains 
higher compared to mortality after mycotic aneurysm. However, long-term 
survival after biological reconstructions is superior to survival after prosthetic 
reconstructions in the context of aortic infections. 
 
2. Biological grafts are infection-resistant in treatment of abdominal aortic infections.  
Furthermore, they spare patients from life-long antibiotic suppression and 
subsequent complications without undermining the outcome.  
 
3. Biological grafts show good durability in midterm analysis after treatment of 
abdominal aortic infections. However, their performance was similar, and no 
single conduit was superior to others. Therefore, based on current evidence, the 
choice of conduit should be made by the surgeon in consensus with patient and 
on the basis of patient’s general condition, availability of graft, urgency of the 
aortic repair and surgeon’s own experience. 
 
4. Ischaemic kidney injury during major aortic surgery can be diminished with 
temporary axillo-renal bypass. It is safe and feasible, with minimal additional 
morbidity.  
 ?
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